

EH


Clinical
dXA
FM
HF pna
molecular_ mechanism

Renal_ artery_ stenosis
exercise cardiovascular_ health
tertiary_ referral centre
devices heart failure

Liver disease adults
inhospital_ mortality
DESIGN Retrospective_cohort
heart transplant recipients
ec
breathing heart beat
DESIGN
Retrospective_cohort
heart_ failure Latin America

HF




doctors


Heart_ rate
Northwest_ United States
Nutrition heart failure
DESIGN
unilateral
surgery
heart failure
INTERvenTIONS

Heart failure

clin
Sci
trans


intermediate_frailty

CHF
dodson


air pollution heart failure
function cardiovascular disease


extracorporeal
temporal_trends HF MI
Heart failure disease
hemostasis
remote_ischemic_conditioning heart_ failure
Heart_ rate_ variability cardiac_ patients
Heart failure UK

CHF
Compliance treatment
Sham-operated_animal
policy


descriptive_onderzoek
taxonomy

doxorubicin injected
Cell Anand
cox_ proportional_ hazards
follow-up
HF
doctors blood transfusions
Heart_ failure bisphosphonates
diuretic heart failure
Caspase-3_ gene_expression heart failure
right_ heart failure pulmonary_ hypertension
benefits cardiovascular_system
europese_HF
Internal_ reliability Cronbach
hypertension
genes
Literature

periprocedural strokes
frailty heart_ failure
HR Ea
treatments
Hazard_ ratios cox regression_analyse
RAS atherosclerosis
patient_ safety
PSSS exercise_training
microRNAs heart failure disease management
exercise heart failure
Cardiology bromodomain inhibition heart failure
management heart failure preserved_ejection_fraction
implanted_monitoring devices
median_âge
AT
Heart_ failure cognitive_ impairment mortality
LV fibrosis ANS_mice
cardiology hospital
HFpEF
current_HF incident_HF
autonomic_ balance
frailty HF
heart failure
ST2 functional
inpatient medical
mitral_ stenosis medical_ treatment heart failure
follow-up
competitive collateral
co mixed_ linear_ models
heart failure hospitalization cardiovascular_ death
cognitive_function
vasopressin congestive_heart failure
cardiac_ transplantation
Jehovahs_ Witness anemia
pde2 HF
Residual_confounding follow-up

black_ patients

metric_ choice readmission_ metrics
mechanism eg CHF
readmission metric

physician_ volume hospital
median follow-up
arrhythmia-related_kosten expenditures
Medication regimen sST2
HF
sts_HM
STUDY_ DESIGN
propensity
mortaliteit
functional_ capacity

Surgical_ tactics circulatory_ arrest
CHF intubated
ejection_fraction sex bNP
Chronic_HF
etiology MR MS
HFpEF
Cardiac_amyloidosis
Pigs antiarrhythmic_ medication
Robot-assisted_training heart failure_ patients
functional_capacite

biomarkers chronic_heart failure
Heart_ rate arterial_ pressure
beta_blockade
hgb level HRQol
cardiac inflammatory_ biomarkers
systolic_ dysfunction
ejection_fraction
HF cardiovascular_hospitalization
heart_ failure
healthcare_programmes
prognostic_ factors


abnormal_ cardiac_t2
drug Japan


VO2max
ESRD
biomarkers
HR HF
mAIN_oUTCOME_measURE tug
heart_ failure

quality_of_ life
Heart_ failure left_ ventricular_ejection_fraction
lVET aortic_ pressure_ curve
Devices heart failureHF therapy
physician_ continuity
Heart_ failure public_ health_problem
Trastuzumab-related_ cardiotoxiciteit breast cancer
Nights hospital
Cardiac
albumin level
Tolvaptan vasopressin receptor
eRK molecular_scaffolds heart_pathology
Functional_ MS degenerative_ MR
Heart failureHF
spironolactone systolic_heart failure
chronic_heart_ failure bisoprolol
cox proportional_ hazards
stand-alone_Diagnos devices HF
HF

therapy
circulation
North America
cPGs
MS surgery
prognosis pathophysiological

AHA ESC
gross_ income expenditure health_ per capita
patients_with_heart failure
lVAD implantation

dialysis_ patients device implantation
cox_ proportional_ hazards
Seattle_ Heart_ Failure_model
heart_ failure


Coronary_Angiography
MS echocardiography
Hemodynamic_ phenotype Fontan
off-pump sternal_ sparing_ approach HeartMate_ II_ exchange
heart failure cox proportional_ hazard_analyses
Nordic_ walking heart failure
multiorgan_ failure sepsis
Pharmacological_ treatment acute_heart_ failure
kidney injury
endothelial_ function flow-mediated_dilatation
Psychometric_ testing Self-Care_of_ Heart_ Failure index

AI
gLS CV_ events AF
mortality
deficit index deficits

follow-up

nursing_ terminologies
race exercise
QRs benefit
guideline MS
skeletal_ muscle_ abnormalities exercise_ capacity Fontan_ circulation
renin-angiotensin-aldosterone_system inhibitors heart failure
CHF unilateral_ renal_ DNx cardiac_ autonomic_ balance
acute_heart_ failure
anaerobic_ threshold heart failure
abnormal_HR_ variability sudden_ cardiac_ death
mAIN_oUTCOME
aac cardiac_ hypertrophy
indices postsystolic
heart_ failure
medication resting_hemodynamics
toxiciteit systemic_ blood_ pressure

mitral_regurgitation HF

systolic_HF
hospital_voor_heart failure
heart_ failure
progressive_ disease hypertension kidney failure
chronic_ kidney diseaseCKd
HF
ICU_ mortality
disease
cRT dialysis-dependent_ patients
CHF
RM
net_economic_ savings
Western_ blot_analyse immunohistochemistry electron_ microscopy
ischemic_ cardiomyopathy male_ sex mortality
idiopathic dilated_ cardiomyopathy
HF chromatin_ hyperacetylation
diastolic_ dysfunction peripheral_ artery disease
unfolded_ protein_ response cardiac sodium_ current systolic_heart_ failure
angiotensin receptor neprilysin_ inhibitor heart failure
hypertensive_ LV dysfunction MR MS
physicians quintilesHF
hypoalbuminemia heart failure
acute_heart_ failure
voordelen anemia_ treatment heart_ disease

algorithms post-LVAD_ AI

care management telehealth medicare
public_reporting
Rhythm-_en_ rate-control strategies
sinus_rhythm AF
diagnosti performance filling_ pressures
Myocardial_infarction Wistar_ rats
prognosis c d HF etiologies
heart_ failure cardiac_ rehabilitation
ingenuity_pathway
Race spironolactone heart failure
proteins TAC
MS mVA
cRF
Mediterranean DASh
social_support exercise
rehospitalization
odds_ ratios accounting hospital clustering
heart_ failure_ clinic
nitroxyl hno treatment_van_heart_ failure
hFrEF HFpEF
Heart block pulmonary_ artery BiVP
blacks VO2
hospital-to-Home congestive_heart_ failure
Cardiac-resynchronization_therapy heart_ failure QRs
physician_ continuity_on_ death urgent_ readmission discharge heart failure

diabetes eEO-cFUs
Care packages
AF echocardiographic_ examination
MSHF surgical_ indication MS
Cardiac_ function pressure-volume_ conductance_ catheter_system
sst2_ concentrations benefit BB_therapy
PVf recovery pb
congenital_heart_ lesions
beta-blockers adherence
follow-up cardiovascular
functional MS
diuretic HF
CAD systolic_HF
bioinformatic_analyse microarray_ data heart_ failure
lVET follow-up_ measurement
inflammation metabolism heart disease
coronary_ disease heart_ failure
hypoalbuminemia lVAD surgery
signalling_ pathways maladaptive_ cardiac remodelling
Fat cachexia ventricle heart_ failure
Atrial_fibrillationAF heart failure
deficit_index biological_ phenotype mortality
resistin_ levels heart failure
AVd VVD free_wall RS
ESRD outpatients HF
Exercise_intolerance chronic_heart_ failure
subclinical_atherosclerosis linear_ models
HF haemodynamic neuronal_stressors
right_ ventricular_function body composition heart_ failure
heart transplantation left_ ventricular_assist_ device
eCGs electrocardiographers
effect heart rate
neurological cardiovascular_ events
dialysis
ff fm FM body weight CC
frailty HF
Cardiac_ cachexiacc
Southeastern_ Minnesota residents HF
multihospital_ study heart failure
AF precipitating_factor hFPEF
proteome HDl_ particles shotgun LC-MSMS
bundle_ branch_ block electrical_activation_sequence
heart transplant ecCT
Protective_effect exercise_trainingET endothelial_function
CV death non-fatal_strot hospitalisation heart failure
ecCT advanced_heart_ failure_therapy
hHF dPP-4 inhibitors drugs
holosystolic_murmur heart
bromodomain_ proteins
heart failure_care
follow-up HF
pharmaceutically_assisted
hypotension
bt DT
therapeutic
Peak_vo2
ST2 plasma samples
follow-up medication
septal_ defects
extubated blood loss transfusion
iCD-HF
miRNAs cardiac_pathogenesis
biomarkers HF

nonfatal_ outcomes
FINdings

trastuzumab-related_ CHF
transplants
aerobic_ exercise
hospitals
economische
patient_ safety
Wilcoxon signed-rank
left_ ventricular_assist device right_ ventricular_support
psoriasis atherosclerosis incident_ cardiovascular_ events Rotterdam
Renal_ artery_ stenosisRAS peripheral_ arterial_ disease
Heart_ failure rheumatoid_ arthritis tNF
Coronary_ artery diseaseCAD systolic_heart_ failureHF
mortality HF hospital admissions transplant ventricular_assist_ device

hospitals
heart failure ejection_fraction
Unilateral_ renal_ denervation autonomic_ balance conscious rabbits chronic_heart_ failure
regulatory_subunitRI HF
nfat mir-25 transcription_ factor_hand2 heart_ failure
VEGF inhibition b cardiac_ function remodeling
Myxomas right_atrium pulmonary_ arterial_vasculature
Right_atrial_myxoma pulmonary_embolism right_ heart_ failure
Orthotopic_heart_ transplantation oHT heart_ failure
coronary_ heart disease stroke heart failure
β-blockerbb sst2
eplerenone
cPET guiding_ exercise_ rehabilitation CHF
ecCT cardiac_ transplant recipients
techniek malfunctioning HeartMate_ II_ lVADs
Heart failureHF cardiovascular_hospitalization
medications adults heart failure
asymptomatic
MLHF
heart failure medication
resistin ejection_fraction
Pediatric_ heart failureHF morbidity mortality
readmissions follow-up_ visits heart_ failure
ischemic_inflammatory_ abdominal_problem MT
band activated_ Caspase paced_myocardium
acr CMS
medline EMBAse cINAHL
renal_ dysfunction post-transplant morbidity
anemia adults heart disease
Heart failure_ disease management
hHF saxagliptin sitagliptin
therapies fes
dysfunction pump failure driveline_ injury isolated_pump replacement
HF
hospital_ discharge
Renal_ DNx circulating_ plasma CHF-inv rabbits
hct germline_DNA genotyped
lVAD implantation
derivation cohort CAD severe_ CAD

treatment
blood_work_ drawn medication
HDl-bound malondialdehyde ec
trastuzumab
NP_ assessment ED
HF
EH HFpEF
Soluble_ ST2 ambulatory_ patients_with_heart_ failure
remote_monitoring hospital_ discharge heart_ failure
echocardiograms
Titin hypophosphorylation myocardialDD
Cardiac_overexpression Mammalian mena heart failure mice
chronic_heart_ failure tachycardia
benefit β-blocker_uptitration HFpEF
coronary_ artery_ diseaseCAD
LV filling_ pressure severe_systolic_HF
Gastrointestinal_ bleeding ventricular_assist_ devices cardiac_ nurse
lVAS bridge_to_ transplantation destination_therapy
soluble sst2 heart_ failure
cPCs functional_capacite VO2
Cardiac_ hypertrophy energie metabolism
east rhythm_control_therapy cardiovascular complications AF
frailty heart_ failure older_ adults
Nicorandil doxorubicin
HF
Heart_t2 heart_ failure arrhythmias
Framingham_ Heart Study HF EF
intubations congestive_ heart failure
diuretics congestive_ symptoms heart failureHF
aCP clinical_ practice guidelines
bottleneck_ stent chronic_ myocardial_ischemia heart failure pigs
iCD-HF
inpatient_ records HF
aRIC_HF
cardiovascular_ reason
pneumonia surgical
therapy

paediatric_ cardiac_ transplants children
AF-free_ probability catheter ablation sinus rhythm
noc
device implantation cRT
HRQoL exercise_training hgb
degs osprey networks
iron
ED CHF
deficit indexSD
Medicare post-acute_care_transfer_policy
benefit QRs

Diet_ score vegetables nuts whole_ grain_ intake mortality
benefit
contrasting_groep interne_ consistency
QT_ intervals SDQT
ventricular_contractile reserve pulmonary_ hypertension
Heart_en_aortic_ blood_ flow doxorubicin
acute_ autonomic_ nervous_system_modulation QTV HF
cardiovascular_ death HF_hospitalization exercise_training btes
cardiac_resynchronization_therapy dialysis-dependent_ patients heart failure
rvpo BiVP co RS synchrony CS
ees ventricular-arterial_ coupling SV
Myocardial_pde2 HF
mapping myocardial_ fibrosis
BAT sympathetic_outflow parasympathetic_activiteit
resistin anthracycline-induced_ cardiotoxiciteit
Low_ skeletal_ muscle_ mass VO2

emergency_ cardiac_ catheterization extubated intermediate_care
atrial_fibrillation pacemaker
pump exchanges pump malfunctions pump thrombosis hemolysis_ events
electronic_ databases world_health_ Organization HF LA
human_miocardial_ tissue pka
body mass index cRF treadmill_ exercise
injections
diastolic_ failure cardiomyopathic_ restriction_to_ flow
autonomic_ nervous_system QTV
psychosocial_ factors exercise_training heart failureHF
hospitalisations readmissions mortality
chronic_heart_ failure high-density_ lipoprotein
ED visits CHF intubation rates
frailty elderly
therapeutic
Medicare fee-for-service
physician_ continuity
Exercise_ attendanceSD diet adherenceSD

bisoprolol reducing_ mortality
pss social_support btes
ethics_ Rounds

cardiac_stress β-AR_ drive
white
parallel-group single-cohort
ivabradine left_ ventricle heart failure
echocardiographic reverse_ remodeling cardiac_resynchronization_therapy
biomarkers neurohormonal_stimulation inflammation endothelial_ dysfunction
medical_management heart_ failure_in_ children Canadian_ Cardiovascular_ Society
Neurohormonal_ abnormalities pathophysiology congestive_heart_ failureCHf
Heart_ Failure Pathophysiology Medical Treatment Guidelines Nursing Management
parasympathetic_ neurotransmission acetylcholinesterase inhibition
end-stage_ renal_ disease systolic_heart_ failure
anemia heart_ disease clinical_ practice guideline American_ College_of_ Physicians
renal DNx cardiac_ autonomic_ balance CHF sympathetic_ tone
right_ ventricleRV cardiac_ function medical
radiological_ signs HF
congestive_heart_ failureCHf
mRI scanner heart failure
Jehovah's_ Witness sickle_ Cell_ disease anemia
chromatin_subproteome mouse_ heart
Mediterranean DASh diet scores mortality heart_ failure Women_s_Health_ Initiative
l-type_ca2_currents Rad congestive_ heart failure
cardiopulmonary_ exercise heart failure
morbidity mortality HF
heart_ failureHF
muscle-wasting_ syndrome acquired_heart_ failure Fontan
miRNAs heart failure
Health_ Buddy_program telehealth_system care management
resistin_ levels anthracycline-treated breast cancer cardiotoxiciteit
dobutamine furosemide_ dose oxygen_ flow
therapeutic heart failure
Mortality aCS
cPCs diabetes
LVEF long-term_ mortality
Health Buddy_program ED hospitalized
inhospital_ mortality bNP
ctnt NT-probNP HF
RV_ dysfunction weight loss fat_lean_ Body_ mass_ ratio
futility safety monitoring_ board
MT abdominal_problem
complication
Thirty-day_ mortality
follow-up
ejection_fraction cardiac_resynchronization_therapy mild_heart_ failure
biventricular_pacing left_ heart_ twist strain porcine_model right_ heart_ failure
Stress doppler_echocardiography pulmonary_ hypertension
aortic_ valve insufficiency left_ ventricular_assist_ device implantation
ventricular_ejection_ time acute_heart_ failure precapillary_ pulmonary_ hypertension
myocardial_ diastolic_ dysfunctionDD collagen deposition titin
co septal_wall_ CS vd free_wall CS VVD
etiologic_ causes acute_RV_ failure left_ ventricular_ dysfunction
left pulmonary artery pulmonary_ artery
student_ t_ test confidence_ intervals cis regression
echocardiography ablation
HR_reduction beta_blockers exercise_ capacity hFrEF
proof-of-principle_cohort Canada
cPCs functional_ capacity heart failureHF
circulatory_assist_ device
sympathetic_activiteit i-MIBG myocardial_washout
circulating_progenitor_ cells heart failure
systolic diastolic_metral_leaflet_ motions
inhibition protein kinase_a soluble_ guanylate_ cyclase contractile_ response
beta_blockers mortaliteit heart failure
PD refractory end-stage_congestive_heart failureCHf
perioperative
trastuzumab cardiac_ comorbidities
economische af heart_ failure Québec
hierarchical_regression
ST2
cardiac_mena_ deletion cardiac_ dysfunction conduction_ abnormalities hypertrophy
bundle-branch_ blockLBbb non-LBbb
CHF_atrial_explants c-Kit_en_cells sham_ explants
HF valve_plasty MS mVA
NYHA functional_ assessment
pressure_ ulcers surgical_ patients
Timed_up_go_ test chronic_organ_ failure
Nursing-sensitive_ outcome_ change_ scores older_ adults heart_ failure
chelation_ regimens heart_ iron
transcatheter surgery
black_race mortality

resistin chemotherapy-induced_heart_ failure humanized_male_mice breast cancer
therapeutic_functions devices fluid overload
nursing hospitalized older_ adultsHF
heart_ failure
echocardiographic invasive_hemodynamic
right_atrium_ mass prolapse tricuspid_ valve stenotic_ physiology
pacing-induced_ dilated_ cardiomyopathy
preoperative_serum_albumin survival left_ ventricular_assist_ device implantation
cardiac_ catheterization thrombotic_obstruction right_ coronary_ artery
Western_ blots monoclonal_ antibodies ser83 phosphorylation HF
Fontan_ failure systolic_ ventricular liver disease
functional_capacite
Chinese_ herbal_ medicine adjunctive_ treatment dilated_ cardiomyopathy heart failure
chronic_heart_ failureCHf sympathetic_ tone autonomic_ imbalance
implantable_ cardioverter-defibrillator_deactivation
mechanistic_ insight prolonged_ electromechanical_delay dyssynchronous_heart_ failure computational
EH cardiac_ filling_ pressures
hFPEF sodium restriction ventricular vascular_ stiffness function
Heart_ failure europese_ society cardiovascular_ diseases
protein levels Western_ blot DNA fragmentation tunel autopsy samples
magnetically_ Levitated_left_ Ventricular_ Assist_system_for_treating_ Advanced_HF
neurological cardiovascular
heart_ failure
HF
MADit-cr_ study device
chemical_instability cogeneration nitrite
Czech Republic
BETs mouse TAC_ model human_HF
dopamine nesiritide
concordance_c_ statistics UM/VA va-RT
transfusion thresholds mortality

cardiac_ nurses

kosten-effective
California_office_of_ Statewide_Health_planning_en_ Development Patient_Discharge
extracorporeal_ membrane_ oxygenation infarction-related refractory_ right_ heart failure
anticoagulation therapy heart_ disease rate_control
Seattle_ Heart_ Failure
Paco2 cerebral_ blood_ flow perfusion carotid_ bodies
pathophysiology HF medical management
ED physicians suburban_hospitals New Jersey New York
heart_ failure protein kinase
cox_regression cardiovascular_ events psoriasis
energy_ metabolism heart_ failure hypertrophied_heart
echocardiography shunt implantation
inotropic_effect beta blockers heart failure
mechanical_ cardiac_support renal_ function
patients ecmo_groep VAD ecmo+VAD
functional MS LV dilatation functional MS
NT-probNP circulation HF
mortality morbidity cancers budget
cutoff_ level NT-probNP
HDl-induced_ NO_ production flow-mediated_dilatation ET
preserved_systolic_function therapeutic
aHF
PAD ankle-brachial index
cPG recommendations HF
isolated_HR ivabradine TAC
TM sts
treatment_groep_effects HRQol
Reasons nontreatment
computing_ readmissions hospital rankings pay-for-performance
iCD
method HF

ventricular_assist_ device extracorporeal_ membrane_ oxygenation renal_ function pediatric_heart_ failure
Cardiorespiratory_ fitness body mass index heart_ failure_ mortality Cooper_center_ Longitudinal_ Study
cox_ models ST2 functional_capacite
New_York_ Heart_association
Exercise_intolerance heart_ failure
pro-adrenomedullinMR-proadm fm
vasopressin_ receptor_ antagonist tolvaptan Japanese_heart failure
functional MS ring_ annuloplasty ischemic_ MR LV dilatation
bNP NT-probNP biomarkers heart failure
psoriasis patients smoked diastolic_ blood_ pressure body mass index
interleukin_ receptor_family_ member ST2 beta-blocker_therapy chronic_heart_ failure
HF cardiac_murmurs blood_ pressure hg
biventricular_ dysfunction isolated_ HeartMate_ II
renal_ dysfunction mechanical_ cardiac_support
ventricular_assist devices device therapies
Functional_ MS medical
ventricular_dilatation dysfunction
aanemia heart disease
heart failure systolic_heart failure
HF spontaneous_VT beat-to-beat_QT intervals
isoproterenol cXL-1020 myocytes hearts
device
pp patients HF
tug_ test advanced_ COPd CHF cRF
Heart failureHF debilitating chronic_ disease
rhythm-control rate-control
HF_ epidemiology health_service_ provision HF LA
hemoglobin
heart failureHF
serum factors markers_for_cogulability
CF lVAD AI heart failure
exploratory_factor_analyse cfa
hemodynamically_ unstable cPR
Nursing social_ mandate
physical_activiteit cardiovascular_ risk factors diabetes mellitus hypertension hyperlipidaemia
diet exercise attention control telephone calls
long-term_ survival
Sudden_ cardiac_ death athletes
hospital_ mortality
administratie trastuzumab-related CHF
rehospitalization
hospitals metric
biomarker-guided clinical
medical_ records
circulating_ fragments natriuretic_peptides plasma heart failure
heart failureHF left_ ventricular_ejection_fractionHFpEF
Pyridostigmine myocyte diameter collagen_ density left_ ventricle
cardiac_ angiogenesis in vivo_ coronary_perfusion cardiac_ fibrosis
implantable_ cardiac_defibrillator
adenylyl_ cyclase g-protein_ coupling
repolarization_instability heart failure ventricular_tachycardia
pressure-overload-induced_heart_ failure
Exercise_intolerance chronic_hFPEF
systolic_HF unclear_ etiology coronary_ angiography
Heart failureHF sympathetic_activiteit parasympathetic_controle heart
ATP demand XO-mediated_ROS mitochondrial_ respiration contractile_function
end-stage_heart_ failure ventricular_assist_ device
Atrial_fibrillation congestive_heart_ failure rhythm-control rate-control strategies
ejection_fractionEF infarct collateral_ growth myocardial_perfusion
HR tNF nbDMARD
Surgical_revascularization catheter-based
Morpholino-based_ knockdown_of_ nucleolin protein_expression
bNP PAD bNP_ measurements HF
CVd psoriasis
Rotterdam_ Study psoriasis cardiovascular
race exercise training ambulatory_HF
HFpEF
parasympathetic_function therapeutic HF
diabetes mellitus cardiovascular_ disease
clinical_ prediction rule CAD systolic_HF
cognitive_impairment mortality
SCHfi
ecmo_groep egFR egFR
haemodynamic pulmonary peripheral_ abnormalities
diagnostic_ performance prediction_ rule
CAD severe_ CAD
HF-related_ cachexia RV_ function body composition
acute_HF
baseline_hgb exercise_training kccq
General_hospital cardiac_specialty_hospital South_dakota
aCS_procedures MT VAD
sonographic histological functional_ abnormalities gastrointestinal
energie substrate_ metabolism isolated_ working_hearts aac
jugular_venous_ pressure peripheral_ oedema volume
Spironolactone hyperkalemia kidney injury
heart transplantationsLV_assist_ device_ implantations heart failure
functional_metral_ stenosis ring_ annuloplasty ischemic_metral_regurgitation
anticoagulants antiplatelet drugs heart failure atrial_fibrillation
mechanical_ cardiac_support renal_ function end-stage_heart_ failure
natriuretic_peptide biomarkers
Heart failureHF
eh systolic_ blood pressure renal_ impairment hypertension
pump-exchange techniek redo_sternotomy cardiopulmonary_bypass
chronic_Myocardial_ischemia heart failure
mouse HF compensated_ LV_ hypertrophy HF hHD
MS HF functional MS medical
sympathetic parasympathetic_activiteit HF
aggressive_ medical_ treatment HF HF HF MS mVA
heart failure preserved_ejection_fraction doppler_echocardiography

HF
health_ insurance health_system_data partners u.s._food_en_drug_ Administration
hereditary congenital_ abnormalities heart nontraumatic_ death sport
Raf-MEK1/2-erk1/2
albumin levels lVAD postoperative
isolated_ HeartMate_ II_ lVAD
bisphosphonate heart failure
sustainability
HF-induced_ remodeling EMd prolongation
MI HF
kosten
maladaptive_ molecular_processes
patient_ safety
Xanthine_ oxidase_ inhibition ventricular_systolic diastolic_ function cardiac_ volume overload
left_ ventricular_ longitudinal_ systolic_ strain cardiovascular_ events atrial_fibrillation
Heart_ failure medicine atheromatous_ coronary_ disease
medications outpatients heart failure NCDR_ PINNACLE
unloading_of_the_heart isolated_HR systolic_heart failure
diagnostic_test HFpEF
HFpEF breathlessheid fatigue fluid retention
circulating_mediator insulin resistance monocytes inflammatory_stimuli
cutoff_waarde NT-probNP
aortic_valve_ surgery post- lVAD
Nordic_ walking cardiac_ rehabilitation_care functional_capaciteit heart failure
spironolactone systolic_heart failure
Cytoscape functional_enrichment_analyse DAVID
blacks hypertension diabetes ischemic_ etiology socioeconomic
immunodetection NT-probNP antibodies
Fontan_ circulation sVR index cardiac_ index pediatric_cohort
mineralocorticoid_ receptor antagonists race
rehospitalization medicare fee-for-service
palliative_care patients terminal disease therapeutic
HF cRThazard_ ratio
lVAD biventricular
oxidative_stress GTPase_ Rac1 hearts ANS_mice
Fontan_ circulation skeletal_ muscle mass metabolic_ abnormalities
right_heart_ circulation right_ heart_ failure
Heart_ failure_HF Latin America lla health service_ planning HF
PD therapy HF


heart failureHF Heart Failure_adherence retention_trialHARt
β-adrenergic_ receptor_blockade cardiac_ failureHF
Myocardial_infarction left_ anterior_ descending_ coronary_ artery occlusion
right_ ventricle overload stroke volume left_ ventricular_ejection_ time lVET
nonselective beta-blockers cardiac_ sympathetic_activiteit hemostasis heart failure
cardiovascular_ death urgent_ cardiac_ transplant
Chromatin-associated_ proteins chromatin_ structure DNA
diastolic_ dysfunction hFPEF
β-Blockade cardiac_ angiogenesis heart failure VEGF
NT-probNP HF_plasma immunoprecipitation mass_spectrometric_analyse
parasympathetic_ tone pyridostigmine ventricular_ dysfunction heart failure
myocardial_ischemic_ events cardiac_resynchronization_therapy
HF preserved_ejection_fractionHFpEF hypertension
NYha functional_class quality-of-life_ score
non-ischemic ischemic_heart_ failure
RV_ dysfunction weight loss abnormal_ body composition HF
heart failure Emergency_ DepartmentED ED volume
gut inflammation dietary_interventions heart failure
CHF emergency_ departmentED intubated
robot-assisted_gait_therapy Lokomat_systeem heart failure patients
exertion therapeutic_ treatments abnormal_ exercise hemodynamic
HR
lVET sensitivity deathICU

Intravenous_ iron heart failure iron deficiency
pPR acr CMS
mortality LCx LAD two-vessel_ disease
stress_ conditions maladaptive_ remodelling heart failure
psoriasis systemicUV
congestive_heart_ failure
Beta-blocker dose resting HR bpm
noninvasive_ tools pulmonary_ hypertensionPH heart failure
conscious white_ rabbits renal DNx pacing-induced CHF
line mutant_mice overexpressing hand2 heart_ muscle_ cells pathological_ hypertrophy
dialysis patients echocardiographic
heart failure reduced_ejection_fraction
QT_ variabilityQTV repolarization lability QTV cardiac_ death
mitochondrial_structure sarcomeric_microstructure
consenting ambulatory_HF patients left_ ventricular_ejection_fraction
et HDl_ function et CHF-NYha-IIIb HDl_ function
aIM implantable_ cardioverter-defibrillator deactivation
microRNAsmiRNAs heart failure
heart rate renal_ function spironolactone
CHF activated_ neurohormonal_systemen
physician_ follow-up_ after_ discharge death readmission heart_ failure
catheter ablation antiarrhythmic drugs rhythm_control_therapy
POc technologie
cardiac_ dysfunction subcellular_ alterations metoprolol heart failure myocardial_infarction
Cardiac_ magnetic_ resonance postcontrast heart failure preserved_ejection_fraction
diastolic_ dysfunction filling_ pressures doppler_echocardiography
impact heart_ magnetic_ resonance_ imaging chelation choices cardiovascular_ disease thalassaemia
Myocardial_ collagen collagen cross-linking titin isoforms phosphorylation
mRI tidal_ respiration myocardial_t1 swine_ with_heart_ failure
RAS-blocker_uptitration hFrEF HFpEF
systems_ proteomics cardiac_ chromatin nucleolin cellular_ plasticity cardiomyocytes
Cardiac_ failure diabetes diabetes heart failure
zSF_ rats heart_ failure preserved_ejection_fraction
Hemoglobin exercise_training chronic_heart_ failure HF-acTION
paradigm-HF chronic_heart_ failure Chronic_heart failure cardiology
arterial_ tonometry_ study lVET precapillary_ PH heart failure
transoesophageal_echocardiography patent thrombosis migration
Cross-talk_ between_de_heart adipose_ tissue cachectic_heart_ failure
readmissions
cardiovascular_ disease
hospital_ rates HF CMS
cutoff e/e_septal
psoriasis cardiovascular_ diseaseCVd
aCS oHT bridged_to_ transplant MT VAD
beta-blocker_therapy

AMI_ mortality
proteins subproteome acid
Plasma samples HF
index admission index admission
early_ medical_management HF
Rhythm_control_therapy
inappropriate_therapy
cardiovascular_ disease dRS
heart failure CLcnka_sNP
miRNAs cardiac remodeling heart failure
AlphaLISa immunoassays NT-probNP
HF rheumatoid_ arthritisRA
transduction_pathways signalling_ proteins
diastolic_ dysfunction
regulation_of_ feeding nutritional anti-inflammatory_effect CHF
pde2-overexpressing cardiomyocytes norepinephrine-induced_ hypertrophic
alendronate risk alendronate heart failure
frailty risk heart failureHF
Bax bcl-2_ proteins
RAS- β-blocker
GDMTcontrol group GDMT BATtreatment_groep
heart failure bisphosphonates
resting HR
β-Blocker-induced_ enhancement cardiac_ angiogenesis therapy cardiac_ function remodeling
nicorandil cytotoxic doxorubicin ehrlich_carcinoma
death c-statistics biological_ phenotype deficit index
Myxomas cardiac_ benign_ tumors left_atrium
natriuretic_peptides
diastolic_ dysfunction hFPEF
Renal_ denervation dx CHF
implantable_ cardioverter-defibrillator deactivation
symptomatic_adult_ FontanSAF
heart failure preserved_ left_ ventricularLV ejection_fraction
ambulatory_ ICD_ patients predictor mortality
sinus_rhythm antiplatelet agents anticoagulants
physician_ follow-up_ after_ discharge physician_ continuity heart failure
MT VAD_groep aCS
cardiotoxiciteit doxorubicin anti-neoplastic_agent cancers
fes preserved_ejection_fractionHFpEF
lifesaving drugs HF ejection_fractionHFrEF
refractory_congestive_heart_ failure peritoneal_dialysis
lVET ICU admission precapillary_ PH heart failure
Myocardial_ loss iRS1 iRS2 heart failure p38alpha_ MAPK insulin resistance
ARNI inhibitorsangiotensin-receptor neprilysin_ inhibitors
Functional_metral_ stenosis m ring_ annuloplasty ischemic_metral_regurgitationMR
heart failure preserved_ejection_fraction hFPEF
Heart_ failure preserved_ejection_fraction hFPef cardiovascular_ reserve
lean zSF1_groep hypertensive obese zSF1 groups hypertensive diabetic
Mammalian_ enabled mena cytoskeletal_actin_dynamics heart failureHF
Gastrointestinal_ bleeding ventricular_assist_ devices
heart failure-related_hospitalization death left_ ventricular_ejection_fraction
activating myocardial_pde2 intracellular_ antiadrenergic_strategie HF
bNP NT-probNP coronary_ artery diseaseCAD
heart failure elevated_ left_atrial_ pressure
hyperkalemia kidney injury spironolactone
Heart_ failure preserved_ejection_fractionHFpEF cardiovascular_ morbidity mortality
eCG cRT
circulating_forms NT-probNP assays
transfusions heart disease
spironolactone
exercise dietcomplementary VO2joint effect
follow-up HF
sst2 BB cardiovascular_event_ rate
breast cancer patients trastuzumb-related_ CHF
PVf pb pb
control group exercise_groep
ecCT
aerobic_ capacity left-hand_grip_ strength body weight waist circumference anxiety
Process_redesign contextual_ framework
tissue doppler_ imaging left_ ventricular_ filling_ pressure systolic_heart failure
heart failure_mice hypertensive_heart_ disease angiotensin_ II infusion nephrectomy salt loading
Kansas City_cardiomyopathy_ Questionnaire heart failure ejection_fraction
guideline anemic iron-deficient_adult_ patients heart disease
heart failure
trastuzumab CHF nontrastuzumab
aggressive_ dose_uptitration HR reduction beta-blocker
coronary_ occlusion collateral_ growth stent occlusion
psoriasis psoriasis
carotid intima-media_ thickness psoriasis
pde2 failing_hearts β-AR_stimulation
Mechanical_ dyssynchrony narrow_ QRs_ complex cRT
remote_monitoringRM heart failure
i heart failureHF death cRT-d
rv dysfunction cardiac_ cachexia
egFR diuretics uncontrolled_ hypertension ESRD
chronic_heart_ failure Hungary
pharmacologic_ treatment pharmacologic
Point-of-care_systemen NP ED community_outpatient_settings acute_heart failure
Renal_ dysfunction cardiovascular_ events caBG
Ea total_ arterial_ complianceTAC end-systolic_ elastance ees
Renal_ dysfunction long-term_ mortality myocardial_infarction coronary_ artery_bypass grafting caBG
cardiovascular_risk factors diabetes mellitus atrial_fibrillation coronary_ artery_ disease HFpEF
coronary_ artery disease systolic_heart failure unclear_ etiology
anthracycline-related_congestive_heart failure haematopoietic_cell transplantation
Biventricular_support HeartMate_ II_ lVAD CentriMag_rVAD
EO-cFUs reducd_ mortalityhazard_ ratio
heart failure ejection_fraction myocardial_infarction
isoprenaline_infusion SDQT hNorm HF
angiogenesis post-myocardial_infarction_heart heart failure
aldosterone_ antagonist heart failure
acute_ heart failure aHF heart failureHF
surgery HF hypertension vasodilators diuretics
HF remodeling EMd dyssynchronous_ failing_heart
Shunt_ implants transseptal_ catheterisation transoesophageal_echocardiographic
dopamine nesiritide pooled_ placebo_groep
hFPEF
MEDline EMBAse cochrane_ databases clinical_ trial registries
egFR VAD_groep ecmo+VAD_groep ecmo_groep
black_race HF cardiovascular_ mortality
biomedical_ reasons nonprescribing
nonprescribing chart_review
HF HF
Care management content-driven_technology health_ outcomes Medicare
lVAS
ERC pure_epicatechin
Ea TAC HR ees ivabradine
physician adherence HF_cPGs
HF_risk factors fit_ men HF_ mortality unfit_ men
HDl_ function CHF ET HDl-mediated_vascular_effect
Pyridostigmine vascular_endothelial_ growth_factor_ protein left_ ventricle myocardial_angiogenesis
idiopathic_ dilated_ cardiomyopathy
quantitative_proteomics chromatin-associated_ proteins detergent disease
tNF antagonists HF hospital admissions nbDMARDs RA
pharmacologic_management acute_HF chronic_HF
HeartMate_ II_insertion biventricular_support HeartMate_ II_ implantation
RV_ dysfunction lower_ body_ mass index lower_ fat_ mass index cachexia
atrial_fibrillation carvedilol metoprolol
baseline_cRF HF_ mortality_ risk HF_risk factors
CHF Classification_of_ Diseases Ninth_revision codes
cardiovascular_ disease heart_ failure
cXL-1020 hno inactive cXL-1051
myocardium_ displays pka downstream_signaling
cardiac_ growth plasticity disease recapitulates chromatin remodeling
elastic_n2bus_ segment PEvk
Robot-assisted_gait_therapy Lokomat_system heart failure
Nicorandil mitochondrial_ dysfunction doxorubicin-induced_heart_ failure rats cardioprotection
RAS hypertension nephropathy congestive_heart failure
brain natriuretic_peptide bNP creatinine natremia
advanced_heart_ failure mechanical_support devices Cardiology-cardiovascular_Surgery Consensus_report Heart failure progressive_ disease
Heart_reduction exercise performance heart failure ejection_fraction beta-blocker hypo-response
SDQT SD RR_ intervalsSDRR index QTV heart rate variability
Self-care_of_heart_ Failure_index SCHfi psychometric_ profile
isoelectric_ focusing RIα ser77 ser83 vivo_phosphorylation
functional MS valve_plasty degenerative_ MR LV disease
management_of_ end_ stage_heart_ failure_ Heart_ failure public_ health
MIs Killip class
myocardial_infarction m heart failureHF
arterial_ elastance ea pulsatile_ afterload heart pressure_ volume_ relation
NT-probNP MR-proANp MR-proadm
heart failure implantable_ cardioverter-defibrillator
HeartMate left_ ventricular_assist_system lVAS heart failure
HF biosynthetic_ enzymes lyso-paf-AT
sst2/low-dose BB sst2/high-dose_bb
HF complicating AMI
zebrafish nucleolin genomic_reprogramming
cardiac_ events
LV_ejection_fraction pcWP
CHF_ visit_ rates ED_ visits CHF patients intubated
gLSHR CV
egFR VAD_groep ecmo+VAD_groep renal_ function
Physician_ volume HF noncardiologist_ physicians
ejection_fraction
risk-adjusted_ mortality
exercise diet
magnet(® research
physician adherence class_ I recommendations
mADIt-cRT multicenter_automatic_deibrillator Implantation Cardiac_resynchronization Therapy
cardiac_ magnetic_reonance_ imaging t1 mapping invasive_hemodynamic_ assessments
Morbidity mortality HFpEF HF EF
Logistic_regression_ models
intravenous_ iron exercise tolerance heart failure
emergency_ department acute_heart_ failure
molecular_ biomarkers pathophysiology chronic_HF therapeutic
knockdown BET bromodomain-containing_ proteinbrd4) cardiac_ tissues
congestive_heart_ failure
eseptal eemean s'septal QRs_width resynchronization
heart failureHF
diuretics HF-related
IVc occlusion co twist apical_ rotation RS RS synchrony CS
carvedilol metoprolol inappropriate_therapy heart failure devices
devices gastrointestinal_ bleeding
heart_ failure follow-up
public_ health air pollution industrial_ areas cardiovascular_ health hospitalisation
Medicare_inpatient HF admissions acute_care_hospitals United States
tidal_ respiration gadolinium-chelate_ contrast agent
HFheart failure t2d type_ 2_ diabetes Skm skeletal_ muscle
catheter ablation atrial_fibrillation heart failure preserved_ejection_fraction
dopamine nesiritide acute_heart_ failure renal_ dysfunction acute_heart_ failure
cardiopulmonary_ exercise_ test quality_of_ life_ score muscular_ strength quadriceps_ force
DAPcdystrophin-associated_ protein_ complex sarcomeric_microstructure
conscious HF_ rats pyridostigmine basal_heart_ rate vagal sympathetic_controle heart rate
eCG congenital_accessory_pathways ion_ channelopathies cardiomyopathy
Dual_RAS neprilysin_ inhibition chronic_heart_ failure systolic_ dysfunction
mouse HF hh salt loading uninephrectomy ANG_ II infusion
HF preserved_ejection_fraction pEF uptitration hospitalization
in-trial_ resource utilization unit_ costs Québec_ Health_ Insurance_ Board kosten Ontario Case_ Costing_ Initiative
idiopathic_ dilated_ cardiomyopathy tuscany
erythropoiesis-stimulating_agent anemia heart disease
mitral_ valve_ plasty degenerative_ mitral_regurgitation
Myocardial_ titin_ hypophosphorylation heart failure ejection_fraction rat metabolic_risk
HFpEF kccq
HF MI preserved reduced_ejection_fractionEF
PD_ initiation weight loss diuretic_ response peripheral_ edema functional_class
serum_ creatinine level serum_potassium
RV_ failure intrinsic_ left_ ventricular_ dysfunction
Mortality inpatient admissions hospital days emergency_ departmentED
Chronic_heart_ failure transforming_ growth_factor_ beta-dependent_ yield atrial_explant-derived c-Kit_
anemia chronic_heart_ failureHF
HeartMate_ II_ lVAD CentriMag_rVAD
follow-up_ visits follow-up
echocardiographic_ score cRT
economische lVAD
heterogenous_ improvement ejection_fraction
AF ablation
Cardiac insulin-resistance mitochondrial_energie production systolic_heart_ failure pressure-overload hypertrophy
If-channel_ inhibition hemodynamic_status exercise tolerance heart failure preserved_ejection_fraction
heart failure heart failure nurses follow-up cardiology
PAf metabolic_ enzymes heart failure
Phosphodiesterase-2 failing_hearts blunts beta-adrenergic_ responses cardiomyocytes
trastuzumab cardiotoxiciteit congestive_ heart failureCHf
total myosin_binding_ protein-c_phosphorylation ser23/24 troponin_ I_phosphorylationHF
renal_ dysfunction stroke myocardial_infarction heart failure caBG
pyridostigmine methylatropine propranolol cardiac_ sympathovagal_ balance
echocardiographic response cardiac_resynchronization_therapy cRT
chromatin_subproteomes heart_ failure proteins chromatin_ structure
circulating NT-probNP antibodies nonglycosylated nonterminal_epitopes
Hum-retn_mice cardiac mRNA inflammatory cell_ adhesion_ genes Retn
nbDMARD tNF antagonist
heart_ failure mechanical_ cardiac_support
hFrEF exercise performance resting HR beta-blocker_therapy
voordelen structured_ exercise_programme heart failure
cox_ hazard_ models ESRD_to_ death ESRD death ESRD

direct_ observation rheumatic MS mVA
pigs inferior_vena_cava icc snared CO
doxorubicin ip serum resistin Hum-retn_mice
nutritional abnormalities CHF fat carbohydrates proteins water micronutrients
kosten high-volume_ physicians
deactivation
University_of_ Connecticut_ Heart_ Failure_ Center cardiologist heart failure_ nurse practitioner
aldosterone_ receptor_ antagonists morbiditeit mortality systolic_heart_ failure
XO inhibition cardiomyocyte_ bioenergetics LV chronic_acf rat
echocardiographic_ measures n-terminal_pro-brain natriuretic_peptide inflammatory_ markers
HF pyridostigmine ejection_fraction cardiac output contractility left_ ventricle
carvedilol thromboembolic_ events heart failure β2-receptor haplotype
uPR protein kinase r-like_er_ kinaseperk calreticulin CHOp HF tissues
heart failureHF cardiopulmonary_ exercise anaerobic_ thresholdAT
randomised-controlled_ trialsRCts observational_cohort_ studies
biomarkers molecular_ dysfunction chronic_HF
CV non-fatal_strot hospitalisations heart_ failure follow-up
sensitivity CAD severe_ CAD
HF
scn5a transcript uPR cardiac_ genes HF
east rhythm_control_therapy AF cardiovascular complications AF
Ambient_air_ pollution cardiovascular_ health acute_Myocardial_infarction
economische NHs behavioural-change chronic_ disease exercise
middle-aged_ recreational_ athletes sudden_ cardiac_ deaths atherosclerotic_ CAD
dialysis-dependent patients HF cRT implantation
Peak_ oxygen_ consumption oxygen_ pulse
RV
post-hCT_ CHF hCT City_of_ Hope
Women_s_Health_ Initiative HF
VAD_groep ecmo+VAD_groep ecmo_groep
albumin levels nutrition inflammation hepatic_ function lVAD implantation
Right_ ventricularRV left_ ventricular_assist_ device lVAD
neurohumoral_blockers HF
ST2 reclassification_of_risk c_ statistic net_reclassification integrated_ discrimination
AMI heart failure kidney infection UTI
cox proportional_ hazards
testosterone_therapy exercise rehabilitation chronic_heart_ failure testosterone status
odds ratiohazard_ ratio HF AMI
tAPse pasp regression_ line_ shift nonsurvivors pasp
ccq kaplan-meier_curves death hospitalization
mAIN_oUTCOME_meaSURES gLS index_ beat_ method CV_ events cox proportional_ hazards
lipolysis energie expenditure natriuretic_peptidesNPs CC
non-ischemic ischemic_heart_ failure biomarkers heart failure
CHF-developed_infarcted_ animals left_ ventricle_ end-diastolic_ pressure
omsted_ County Minnesota MI diagnosed HF
hearts mena cardiac_ injury mena HF_pathophysiology
RAS doppler_ ultrasonography computed_tomographic_angiography magnetic_reonance_angiography
lVAD transplantation
diagnoses
cRT-d IE defibrillator-only_therapyHR
IC multicenter_automatic_deibrillator Implantation trial-Cardiac_resynchronization Therapy
Health_ Buddy_programm chronic_obstructive_ pulmonary_ disease mortality congestive_heart_ failure
Cardiopulmonary echocardiographic myocardial_function left_ ventricular_ filling
speckle tracking echocardiography ste BiVP right_ ventricular_ pressure overloadRVPO
hypoalbuminemia postoperative_ mortality left_ ventricular_assist_ device lVAD
inhibition_van_ vascular_endothelial_ growth_factorveGF compensatory_ hypertrophy cardiac_ failure
left_ ventricular_ejection_fraction long-term_ mortality heart_ failure Heart_ Failure_ Survey irael
obesiteit diabetes mellitus metabolic_risk_ factors heart_ failure preserved_ejection_fraction
nicorandil cardioprotection apoptotic_signaling_ pathway DNA fragmentation mitochondrial_ ultrastructural
percutaneous_ coronary_revascularization hemodynamically
therapy atrial_fibrillation atrial_tachyarrhythmias ATP shock_therapy
pathophysiologic_ mechanism stems renal_underperfusion renin-_ angiotensin-aldosterone
proteomics pressure-overload-induced_heart_ failure mitochondrial-targeted_peptides
dose_uptitration HR_reduction
ANS_mice LV fractional_shortening lung_weight
functional_enrichment_analyse programmed_cell_ death degs
Rad_ variantQ66p congestive_ heart failure
PERk inhibition scn5a kv4.3 mRNA mRNA splice
systolic_heart_ failure spironolactone
eCG atherosclerotic_ CAD sudden_ cardiac_ death
HR_dynamics spectral non-linear_meters HR variability risk_ stratification
sex EF bNP HF bNP sex EF
HF index AMI adjusted_ hazard_ ratio
BETs transcriptional_ pause_ release transcription pathological_stress
apoptosis pathogenesis heart_ failure
diuretic_efficacy neurohormonal_activation fluid overload
uPR na+_ channel mRNA splice cardiac_na+_ current human_HF
LVEF LVEF
mena expression HF mena cardiac_pathophysiology
NP_ measurement POc NPs clinical_care delivery
RECENT_ FINDINGs intestinal_morphology permeability absorption_ function CHF
benefits follow-up
fibrosis_of_heart_ failure_ myocardial_ tissue left_ ventricular_ tissue trichrome_blue_ histologic
tricuspid_ annular_ plane systolic_excursion pulmonary_ arterial_ systolic_ pressure heart_ failure index right_ ventricular_contractile
atrial_fibrillation Atrial_fibrillation Stroke prevention trial
Kansas City_cardiomyopathy_ Questionnaire kccq HF EF HFpEF
Trastuzumab CHF nontrastuzumab_ usershazard_ ratioHR
Blood pressure arm cuff stroke_ volume v ejection_fraction end-diastolic_ volume echocardiography
atrial_fibrillationAF heart failureHF stroke anticoagulation
salt loading uninephrectomy ANG_ II_infusion_ mouse_ model cardiac_ function mice HF
bottleneck_ stent myocardial_infarction antiplatelet medication
LVEF long-term_ mortality acute_decompensated_HF
echocardiographic_ score LV reverse_ remodeling
Fontan_ failure circulatory_derangement hemodynamic portal_ hypertension cardiac_ output
biventricular_support hybrid_systeem HeartMate_ II_ lVAD CentriMag right_ ventricular_assist device rVAD
HF-action_cohort hgb baseline_ HRQoL kccq
functional MS valve plasty annular_ size reduction degenerative_ MR LV disease
combined_training peak_work rate peak_ quadriceps_ force
pathological_ remodelling heart cardiac_ hypertrophy HF fibrosis inflammation
idiopathic_ dilated_ cardiomyopathy
functional MS valve_plasty degenerative_ MR LV disease
frailty heart failureHF
high-volume_ physicians
EO-cFUs cd34vegFR2_ cells functional_ capacity nondiabetic_ patients
etiology comorbidities
ARNI cardiovascular_ mortality hospitalization heart_ failure quality_of_ life
right_ ventricularRV body composition advanced_heart_ failureHF
myocardial_DD muscle_ strip stiffness titin hypophosphorylation
proteins cardiac_ hypertrophy nucleolin
exercise_training HF
anaerobic_ metabolism respiratory_quotient
borderline preserved female
virtual_cohorts
cardiac_ magnetic_ resonance amyloidotic multiple_ myeloma osteomedullary_ biopsy
Low-sodium_ DASh diet diastolic_function ventricular-arterial_ coupling hypertensive_heart_ failure preserved_ejection_fraction
Vascular_endothelial_ growth_factor_ blockade beta-blocker_therapy cardiac_ function angiogenesis remodeling heart failure
implantable_ cardioverter-defibrillatorsicds cardiac_resynchronization_therapy cRT
HFpEF echo-Doppler_cardiography invasive haemodynamic_ assessment
RAS- β-blocker_uptitrations hFref HFpEF
ventricular_assist_ deviceVAD extracorporeal_ membrane_ oxygenation ecmo renal_ function
American_ College_of_ CardiologyAmerican_ Heart_association RAS
LV diastolic_ properties XO_ inhibition heart failure
contractile function LV dilatation LV end-diastolic_ pressurewall stress lung_weight
circulating_progenitor_ cells cPCs endothelial_ repair cardiovascular_ diseases
implantable_ cardioverter-defibrillator_ deactivation heart failure
NT-probNP plasma dyspnea left_ ventricular_ dysfunction ED
Caucasian sNP ka renal_ chloride_ channel_ geneCLcnka
Physician_ volume medically_ managed_ diseasesHF
frail intermediate_frail
LBbb implantable_ cardioverter_defibrillator-cRT
RM_strategies wind_ failure
exercise-induced pasp hg pasp
eplerenone HF-ref hyperkalemia wRF
t1-mapping_techniek diffuse_Myocardial_ changes heart failure contrast agent breath-holding
bt DT
hFPEF longitudinal_ outcome-monitoring_ phase cardiac_event
expenditure health_ per capita gross_national_ income_per_ capita HF
AF pharmaceuticals hFPEF
is cRT-d heart failure
SDQT HFVT HFVT hNorm_groep fixed-rate_atrial_pacing
bNP inhospital_ mortality p
blood pressure_controle goal-directed_ lipid-lowering_therapy smoking cessation RAS
QRs morphology cardiac_resynchronization_therapy cRT
mitochondrial_ complex_v_activiteit aac phosphocreatine ATP
Yorkshire_ swine pacemakers ventricularly_ paced heart failure
heart_ failureHF implantable_ cardioverter_defibrillatorsicds
Cardiovascular_outcomes Renal_ Atherosclerotic_LesionscoRAL stenting RAS
MI_animal metoprolol plasma norepinephrine dopamine epinephrine
ST2 cardioprotective_signaling myocardium biomarker heart failureHF
skeletal_ muscle_ sarcomere_ structure heart failure diabetes epicatechin-rich_ cocoa
aberrant_reactivation_of_embryonic_ gene programs pathological_heart_ disease transcription factors gene programs
isolated_heart_ rateHR ivabradine systolic_heart_ failure
mDC
acute_heart_ failure aHF
multiparametric_echocardiographic_ score reverse_ remodeling cRT
biomedical_ treatment CHm biomedical_ treatment dCM heart failure
centrifugal_ flow_pump hemocompatibility magnetically levitated_ rotor blood-flow_ paths artificial_ pulse
sst2/low-dose BB sst2/high-dose_bb cardiovascular_ events
Mediterranean_dietary_approaches_to_ Stop_ HypertensionDASh diet scores mortality postmenopausal_ women HF
POc systems_voor_measuring_NP_ levels
functional_capacite
echocardiography cardiac_ diameters cardiac_ function vehicle-treated rats
lb QRs implantable_ cardioverter_defibrillator-cRT
risk-adjusted_ mortality readmissions costs
electronic_ databases medline EMBAse PsycINFO
factorial_ trial urban_ academic_medic center
therapeutic left-to-right_interatrial_ shunting heart failure ejection_fraction
systolic_HF cXL-1020 left_ right_heart filling_ pressures systemic_ vascular_ resistance cardiac stroke volume index
heart failure hypertension mitral_regurgitation mitral_ stenosis heart failure
PERk activation scn5a kv4.3_ channel mRNAs transient_ receptor_potentication_ channel m7TRPM7_ channel mRNA
implantable_ cardioverter-defibrillator Heart_ Function_ Clinic university_health_ NetworkToronto,_ Canada
cardiovascular_ death stroke heart failure myocardial_infarction
Exercise-induced pasp pulmonary_ hypertension ventricular_contractile reserve
antagonists inhibitors renin-angiotensin-aldosterone sympathetic_ nervous_systemen CHF
Cardiac-resynchronization_therapy cRT morbidity mortality chronic_ systolic_heart_ failure QRs
truncated_na+_ channels unfolded_ protein_ response uPR scn5a electric_ remodeling HF
international_ Right_ Heart_foundation_working_groep right_heart_ failure
myofiber_dynamics myofiber_shortening EMd dyssynchronous_HF
crude ankle-brachial_index pulse-wave_ velocity coronary_ artery calcium scores
allopurinol contractile_function efficiency XO-mediated_ROS_effect myofilament sensitivity
antiplatelet agents anticoagulants vascular_ diseases
cardiac_ hypertrophy pressure-overload abdominal_aortic_constriction aac
HF HF HF epidemiology SH c'd rheumatic_fever
guideline-recommended medications heart failure reduced_ejection_fraction
caloric_ restrictiondiet aerobic_ exercise_training_exercise exercise_ capacity QOL obese_ older_ patients hFPEF
chronic_heart failureHF hemodynamic_ disorder syndrome dysfunction interconnected_ molecular_ pathways
HFpEF diastolic_ filling_ time controlling_ heart_ rate
hgb kccq_ scales hgb exercise_training HRQol
heart_ failure hospital_ discharge readmissions follow-up
mice cardiac_ myocyte-specific mena overexpressionTTA tgtetMena cardiac_ pathology
Fontan_ failure hemodynamically heart failure systemic_ vascular_ resistance sVR index preserved_ cardiac_ index
isolated_heart_ transplant ecCT
r._ Cluster_analyse
AT metabolic_ exercise cardiac kidney index score
heart failure refill compliance etidronate alendronate
physicians advanced_heart_ failure
therapeutic_strategie AF severe_heart_ failure financial_ burden
therapy comorbidities
et_en_ HDl-mediated_ protective_effect molecular_ pathways chronic_heart failureCHf
rehospitalization Medicare_hospital_ claims Medicare post-acute_care_transfer_policy
physical_activiteit cRF HF_ mortality
followup_ body_weight FM fFM CC
intermacs interagency_registray_voor_ Mechanically_ Assisted_ Circulatory_ Support
eccentric concentric_ left_ ventricular_ hypertrophy heart failure preserved_ejection_fraction
left_ ventricular_ejection_fraction heart failure preserved_ejection_fractionHFpEF
left_ ventricular_ejection_fraction left_ ventricular diastolic_ end_ diameter
β-adrenergic_ receptor_blocker_therapy myocardial_perfusion neoangiogenesis failing_heart
extracellular_ matrix left_ ventricular_ biopsies tissueFAXs technology
hART HFpEF HF_met_ reduced_ejection_fractionHFrEF
conscious_dogs tachypacing-induced HF cXL-1020 contractility end-systolic_ elastance venoarterial_dilation
actin_ cytoskeleton mitochondrial_ function intermediate_ metabolism glycolysisgluconeogenesis citrate_ cycle
elevated_ resistin anthracycline-induced_ cardiotoxiciteit heart failure macrophages
bone_ morphogenetic_ protein rRNA transcription heterochromatic_ chromatin
left_ ventricular_assist devices lVADs cardiac_ failure pump dysfunction pump replacement
scn5a AngII hypoxia uPR
current_HF odds_ ratio 28-day_ mortality hazard_ ratio
AAs HF hyperkalemia hypokalemia spironolactone
bNP diastolic_ dysfunction
dopamine nesiritide decongestion renal_ function
NT-probNP assay nonterminal_epitopes glycosylated_region
receptors g-protein-coupled_ receptor kinase-2
systolic_function HFpEF long_axis_ function exercise
ST2 amino-terminal natriuretic_peptide
aanemia iron_deficiency MEDline cochrane_ Library
metric
creatinine bNP furosemide_ dose oxygen flow dobutamine norepinephrine
biomedical_ treatment CHm biomedical_ treatment dCM heart_ failure PubMed
myocardial_ collagen myocardial delayed_ enhancement_ imaging
sst2/high-dose_bb sst2 bb cardiovascular_ event
Sprague-dawley rats sham aCF allopurinol
Biventricular_pacing biVP cardiac_ outputco cardiac surgery
saxagliptin sitagliptin follow-up pairwise
kccq_ domains interne_ consistency HFpEF cronbach
implantable_ cardioverter_defibrillator-cRT non-LBbb QRs
alendronate etidronate- raloxifene-treated
diagnoses
systolic_HF Danish_ Heart_ Failure_ database ESRD Danish_ Registry_ on_dialysis
chemotherapy trastuzumab CHF international_ Classification_of_ Diseases healthcare Common_ Procedure_coding_system codes
contemporary_heart_ failureHF therapies HF preserved left_ ventricular_ejection_fractionLVEF
cr_groep control_groep hazard_ ratio
m_groep
risk Hospitalized_ Heart_ Failure Saxagliptin sitagliptin antihyperglycemic_drugs
race exercise_training chronic_ heart failure Heart_ Failure controlled_trial_ Investigating Exercise_ TraiNingHF-action
intraclass_ correlation_coefficient icc kappa coefficient mDC
Nicorandil phosphocreatine adenine_ nucleotides mitochondrial_ oxidative_phosphorylation capacity creatine kinase_activiteit
cox proportional_ hazards_ models death transplantation LV_assist_ device_ implantation heart failure
neurohormones adipokines body composition CC fat free_ mass fm fat_ massFM
Swedish_national_inpatient_registray rehospitalization stroke myocardial_infarction heart failure caBG
mistargeting altered_regulation Rad_ Q66p rGK_ protein
Catheter ablation AF compensated_hFPEF left_ ventricularLV ejection_fraction
Myocyte_ hypertrophy_ antecedent_to_ heart_ failure
fully_magnetically_levitated_ lVAS Seattle_ Heart_ Failure
AlphaLISa immunoassays antibodies circulating NT-probNP
cardiac_ plasma membrane s1PR1 β1AR overstimulation heart failure
New York_ Heart_associationNYha chronic_heart_ failure reduced_ejection_fraction
biological_ phenotype deficit_index medical_ records frailty
tunel_assay apoptotic_ cells tunel-positive_ cells paced_groep
SDQT HFVT hNorm β-adrenoceptor_blockade esmolol
surgically_ induced myocardial_infarction heart failure bisoprolol vehicle
ss_HH TM medical_support
congestive_heart_ failure non-urbanized_midwestern_ state South_dakota
tachycardia intravenous_atropine cardiac_ vagal_ tone CHF-DNx CHF-inv animals
cardiomyocytes mechanical humoral_stimuli myocardium workload stress
tAPse pasp length-force_ relationship RV_ function_ evaluation LV_ dysfunction
biventricular_support rVADs
functional_efficacy pure_hno_ donor myocardial_ function HF
transitions_of_care_programme self-management_training patients follow-up
ESRD systolic_HF egFR
CHF cardiac_explant c-Kit_ progenitors mechanisms
BB therapy sst2_ measurement chronic_heart_ failure BB
STUDY_ DESIGN heart failureHF acute_Myocardial_infarctionAMI pneumonia
heart failure left_ ventricular_ejection spironolactone Kaiser_ Permanente_ Northern California
echocardiographic_ score LV reverse_ remodeling LV end-systolic_ volume
renal_ dysfunction cardiovascular_ eventsstroke myocardial_infarction heart failure coronary_ artery_bypass grafting
aldosterone_ antagonist_therapy chronic_heart_ failure post-myocardial_infarction_ heart failure
left-to-right_interatrial_ shunting heart_ failure ejection_fraction
myocardial_extracellular_ matrix cardiac_ magnetic_ resonance_ T1_ mapping pathobiologypathophysiology prognosis
bMI heart rate rhythm lying standing_ blood_ pressure auscultation valvular_ disease pulmonary_congestion
Peritoneal_dialysisPD diuretic_ resistant_ volume overload heart failureHF
Cardiology practices europese_ Cardiovascular_ Disease_ Registry Practice Innovation Clinical_ Excellence
hno_ donor cXL-1020 isolated_myoctyes intact_ hearts heart failureHF
peripheral_ muscle_pump cardiac_ filling subpulmonary_ ventricle Fontan_ circulation
Nicorandil heart_ rate aortic_ blood flow mitochondrial_ oxidative_stress doxorubicin cardiotoxiciteit
Renal_ dysfunction heart failureHF dysfunction end-stage_ renal_ disease eRD
heart failure preserved_ejection_fraction hFPEF heart failure overweight obese
Peripheral_ artery_ diseasePAD heart failureHF HF PAD
heart_ failure CHAr_programmeCandesartan_in_ Heart_ Failure_ Assessment Mortality Morbidity
asymptomatic_ pediatric FontanPF catheterization
leaflet serial_ evaluation MS subvalvular annular MS fixed_ ring_ size
Lancet Anoop_ Shah air pollution heart failure morbidity mortality elderly_personen
cell therapy chronic_heart_ failureCHf disease explant-derived_progenitor_cells
obese_ older_ patients hFPEF caloric_ restriction aerobic_ exercise_training VO2
anemia HF health-related_quality_of_ lifeHRQoL HF
mRI-based dyssynchronous_nonfailing HF canine_ electromechanics
HR_ variability mortality AMI CHF_LV_ dysfunction
race chronic_heart failureHF exercise_training_ response
follow-up
exercise cell senescence malignancies cancer prostate colon osteoporosis depression dementia
capillary coronary_perfusion ad-flk rats ad-c_ rats
shuttle_ walk_ test body mass hand_ grip_ strength
physician_ volume mortaliteit internists cardiologists
protocol-driven POc_ testing NP patient consultation ED
Troponin_t n-terminal_ pro-b-type_natriuretic_peptide biomarker_ approach heart failure_ risk atherosclerosis
acute_RV_ failure chronic_ pulmonary_ arterial_ hypertensionPAh acute_ pulmonary_embolism
tachycardic_ response methylatropine vagal_ tone bradycardic_ response propranolol sympathetic_ tone
neprilysin inhibitors natriuretic_peptide atrial natriuretic_peptide natriuretic_peptide
Tools_economic_analysis_of_ Patient Management_ Interventions_in_ Heart_ Failure
fractional_ flow reserve positron_emission_tomography_ imaging ischemia bottleneck_ stenting left_ ventricle proximal_LAD
cardiac_resynchronization_therapy cRT mild_heart_ failureHF QRs prolongation ejection_fractionEF
mitochondrial_ oxidative_phosphorylation capacity creatine kinase_activiteit oxidative_stress_ markers DNA fragmentation ultrastructural
ventricular_assist_ devices cardiac_ nurses gastrointestinal_ bleeding
cox_regression spironolactone death hyperkalemia kidney injury
cardiac_ transplant ecCT transplant_ pool
septumsystolic_ thickness LV posterior_ wall_ thickness LV internal_ diameter metoprolol
BAT n-terminal_pro-brain_ natriuretic_peptide HF
American_ College_of_ Physicians aCP anemia iron deficiency heart disease
mortality hospitalization mortality cardiovascular_ mortalityHF_hospitalization cox_ models exercise_training
HF_ registry dichotomized patients HF EF HFpEFEFEFEF
Functional_elektral_stimulation peripheral_ muscles endothelial_function heart failure left_ ventricular_ejection_fraction
SDQT-to-SDr_ ratio HFVT HFVT hNorm
ventricular_structure geometry fibersheet_orientation handling slowed_conduction wall stiffness
Rad Q66p cardiomyopathy mechanism
serum resistin women anthracycline-containing_chemotherapy cardiotoxiciteit
sst2 bb cardiovascular_event_ rate
postoperative_ survival hypoalbuminemia albumin_ concentration
renin-angiotensin_system_ blocker beta-blocker_therapy heart failure left_ ventricular_ejection_fractions
Exercise Medical Therapies Cardiac_ Function Shortness_of_ Breath_ Due_ to_ Lung_congestionACTRN
cardioprotective_effect nicorandil hemodynamic_ alterations mitochondrial_ dysfunction doxorubicin rats
Baroreflex_sensitivity time domain_ heart_ rate variabilityHRv CHF-inv sham-inv sham-inv renal_ DNx
haematopoietic_ cell transplantation hCT congestive_ heart failureCHf hCT anthracyclines
epigenetic_writer_ proteinshistone_acetyltransferases epigenetic_erasershistone_ deacetylases cardiac
NT-probNP mortality acute_HF
in vivo_ inhibition mir-25 antagomir spontaneous_ cardiac_ dysfunction murine_myocardium heart failure hand2-dependent
bundle_ branch_ block electrical_activation dyssynchronous_heart_ failureHF electromechanical_ behavior heart
nurse cognitive_ impairment physician discharge elderly_ patients heart_ failure
hypertension diabetes mellitus systolic diastolic_murmurs
advanced_heart_ failureheart_team cardiologists cardiovascular_ surgeons medical_ staff
Chinese_ herbal_ medicineCHm dilated_ cardiomyopathy dm heart failure
TAPse pasp nonsurvivors hFref HFpEF
acute_RV_ failure pulmonary_embolism mortality
bisphosphonates alendronate etidronate heart failure refill compliance
HF-action HF HF ejection_fraction
carvedilol nonselective β-blocker β-blocker metoprolol thromboembolic_ events heart failure
HF AMI pna mortality
cardiac_ transplant_ survival ecCT
heart_ failureHF HF
arrhythmia substrateAMI HR arrhythmia_ events
hypertension compensated_hFPEF DASh srd sodium kcal
deranged_ca(2+) handling EMd dyssynchronous_HF remodeling
ejection_fraction cardiac index inotropes inotrope-dependent medical_management transplant
doxorubicin-induced_ cardiotoxiciteit Hum-retn_mice littermate resistin retn
diastolic_ dysfunction pathophysiology HFpEF non-diastolic_ abnormalities cardiovascular_function
8-fluo-cAMP binding phosphomimic ser77 ser83 mutant RIα proteins double_mutant wt_riα
high-density_ lipoproteinHDl endothelial-protective endothelial_ cell ec nitric_ oxide no
dialysis HF
admission_to_ discharge older_ adults heart_ failureHF Nursing_outcomes Classification noc
hHF saxagliptin sitagliptin antihyperglycemic_agent
preoperative_albumin mortality lVAD
systolic_heart_ failure QRs cRT cardiac_ failure mortality
degs non-ischemic ischemic_heart failure
reoperation bleeding driveline_ infection gastrointestinal_ bleeding debilitating_ stroke Rankin_ Score
cox regression_ models propensity_ score decile oral glucocorticoid loop_ diuretics
insulin_ resistance type_ 2 diabetes insulin receptor_ substrates irs2 insulin-signaling
dyssynchronous_HF electromechanical_delay eemd myocyte depolarization myofiber
Beta_blockers mortality readmissions heart failure ejection_fractionHFrEF heart_ rateHR
Functional_elektral_stimulation fes exercise capacity emotional endothelial_ function chronic_heart failure systolic_function
right_atrial_ myxoma massive_embolism pulmonary_ arteries right_atrial_ mass_ removal pulmonary_embolectomy
transplant ineligible patients PD HF volume managementPD
biomarker_studies biomarker-guided_ clinical_ trial therapeutic
imaging abnormal_liver_ textures nodularity
frailty biological_ phenotype weak_grip_ strength physical_ exhaustion slowness unintentional_gewicht_ loss
cRT-d IE IC cRT-d IEs
EDs discharge patients heart_ failure_home low-volume_ ED_ cases readmissions ED
QRs morphology cardiac resynchronization_therapy resynchronization-Defibrillation ambulatory_ Heart_ Failure_trialRAFt
acute_ right_ heart_ failure therapy refractory_ cardiogenic_ shock heart_team corporeal_ membrane_ oxygenation ecmo cPRICU
guidelines undiagnosed_heart_ disease HF surgical_ palliation
Gene_expression_of_ Bax bcl-2 mRNA_expression moderate_ heart failure bcl-2/Bax
heart_ magnetic_reonance_ imaging chelation_ choices patient_ compliance heart failure arrhythmias
nitroxyl hno Angeli_s_ salt inotropic lusitropic vasodilator effects cAMP
ejection_fractionEF pre-PD NYHA_ class_ IIIb right_ ventricular_ dysfunction
cPCs early-outgrowth colony-forming_ units o-cFUs circulating cd34 vEGFR2 cd133
continuous-flow_ lVADs heartMate_ IIHM_ II HeartWare bt DT
anticoagulation rate control cardiovascular complicationsstroke cardiovascular_ death acute_heart_ failure atrial_fibrillationAF
EF blinded_ core_ laboratory
bNP inhospital_ mortality
DASh diet scores mortality HF Mediterranean_diet scores
skeletal_ muscle_ mass appendicular_ lean_ mass index z-score
ST2 functional_ capacity well-treated ambulatory_ patients HF
Quality_of_ life all-cause_ mortality
Gene_expression_ profiling cultured_ cardiomyocytes jq1 drug phenylephrine-induced_ genes
CLcnka polymorphism arg83gly heart failure glomerular_filteration rate reNAStur
cardiovascular_ diseases heart failureHF HF
cardiac_veGF_expression Akt endothelial_no_ synthase_activation failing_hearts
Psychosocial_factors Exercise_adherence Heart Failure Patients Insights Heart_ Failure Exercise_trainingHF-action
heart failure left_ ventricular_systolic_ dysfunction BB
derivation_cohort coronary_angiography systolic_HF unclear_ etiologyejection_fraction
cardiac_ insulin-resistance aac insulin-stimulated_ rates glycolysis glucose_ oxidation plasma membrane translocation glucose_ transporter
angiotensin_ IIAngII hypoxia activators scn5a mRNA splicing overexpress scn5a
exercise-induced_pasp ventricular_contractile reserve exercise-induced_pasp
arterial_ elastance ea end-systolic_ elastance ees ventricular-arterial_ coupling ratio ees ees
post-DASh srd_brachial_central_ blood_ pressure radial_ arterial_ tonometry cardiovascular_ function echocardiographic
Gene_expression_ profile gse9128 Gene_ Expression_ Omnibus non-ischemic_heart failure ischemic
rhythm_control_therapy antiarrhythmic drugs catheter ablation electrocardiographic_ device rhythm
expenditures noncardiovascular diagnoses implantable cardiac_ arrhythmia devices noncardiovascular_ drugs
HF_met_reducingd_ejection_fractionHFrEF treatment HF_met_ preserved_ejection_fractionHFpEF
extracorporeal_ life_support bridging_therapy acute_ischemic_ right_ heart failure refractory_ cardiogenic_ shock reperfusion therapy
heart failure left_ ventricular_ejection_fraction fes exercise_ capacity endothelial_function HFpEF
intubation_ rates
hearts tgtetMena_mice wild-type_ littermates heart mass transgenic_mice
raloxifene mechanism_of_action heart failure
hFref respiratory_gas_analyse
guideline-recommended_ drugs_voor_heart failure chart_review biomedical_ reasons nonprescribing
black_race chronic_HF modifiable_risk_ factors exercise performance HF hospitalization mortality exercise training
wasting_of_ fat lean_ mass fat_ loss enhanced_ catabolism adipose_ tissue cardioprotective HF
lVADs CF_ devices HeartMate_ II_ devices thoatec_ Corp Pleasanton calif hVAD_ devices heartWare_intl_ Inc Framingham Mass
hearts nucleolin chamber_ patterning cardiac looping myocyte
plasma collected HF immunoreactive NT-probNP
FM plasma NPs total_ adiponectin FM fm NPs adiponectin follow_up
Macrophages cardiomyocytes Hum-retn_mice doxorubicin hremnhuman_ resistin mRNA protein expression
beat-to-beat_QT_ interval eCGsatrial pacing esmolol isoprenaline atropine_infusion
sympathetic_ tone parasympathetic_ tone heart rate_ response metoprolol atropine
EH HFpEF HF_met_ reduced_ef hbfrEF hFrEF therapy
adverse_ event_ rates acute_Myocardial_infarction congestive_heart failure in-hospital adverse_ events

follow-up_ visits
transcriptional_analyse cardiac_ tissue mice TAC- sham-operated jq1 vehicle BET_ inhibition pathological_ cardiac_ gene expression_programme
power_ spectral_analyse low-frequenncy high-frequenncyLFHF CHF-inv sham-inv sham levels DNx
natriuretic_peptident-probNP misdiagnosis heart_ failureHF
HF-action left_ ventricular_ejection_fraction New_York_ Heart_association HF exercise_training
myocardial_DD collagen deposition titin_ modification obese diabetic zSF1 rats heart failure preserved_ejection_fraction
cardiac_ magnetic_ resonance postcontrast_t1 hFPEF postcontrast_t1 biomarker hFPEF
contractility ventricular-arterial_ coupling SV ivabradine-treated
conditional_ge-targeted_hand2_mice pressure-overload-induced hypertrophy fibrosis ventricular_ dysfunction fetal_ gene_programm
cutoff_waarde admission NT-probNP ED acute_HF diagnosis
clinical_ prediction rule CAD angiography systolic_HF kosten
epigenetic_ readers cardiac_ biology cardiac_ gene_control chromatin-dependent_signal transduction pathological_ gene_expression HF progression
systolic_ blood_ pressure left_ ventricularLV_ hypertrophy AT AN AS ANS_mice
follow-up heart failure sudden_ death noncardiac cardiac_ transplant
percutaneous_revascularization angioplasty stenting
load-corrected_ chronotropic_ response heart_ rate exercise follow-up_ tests heart rate
Peak_ oxygen_ consumptionVO2max resting_HR bpm mL
cox-proportional_ hazard models negative_binomial_regression models
HF t2d consumed ERC treadmill_ testingVO2max oxygen_ consumption Skm biopsies
gastrointestinal_ bleeding incessant_ ventricular_tachycardia storm terminal_heart_ failure
Chronic_ β-AR catecholamine infusions rats pde2 cAMP hydrolytic_activiteit blunted_ cardiac β-AR_ responsiveness
HF QRs prolongation LVEF cRT reverse_ remodeling LV_ systolic_ dysfunction
chronic_pAH RV decompensation pharmacologic_therapies RV failure_management pAH

comanagement medication
non-frail_ participants moderateHR severe_frailtyHR Gill index HF
frailty health ABC_short_ Physical_ Performance_ Battery hABC_battery Gill index HF
RV_support lVAD_insertion cardiogenic_ shock myocardial_infarction chronic_decompensated_heart failure
Chronic_heart_ failureCHf multisystem_ disease anemia insulin resistance autonomic_ dysbalance cardiac cachexia
Xanthine_ oxidaseXO rat left_ ventricularLV myocytes volume overloadVO mitral regurgitation aortocaval_fistula acf
obese zSF1 groups heart_ failure preserved_ejection_fraction lung_ weight preserved_ left_ ventricular_ejection_fraction left_ ventricular DD
high-volume_ physicians mortality low-volume_ physicians low-volume_hospitals
Western_ Australian_linked_administratieve_gesundheit HF index AMI
europese
nursing-sensitive_ outcome_ measures science HF
HF AMI adjusted_ odds ratio ci
miRNAs noncoding_RNAs binding messenger_RNA degradation translational_repression
free-breathing_ pulse_sequennce myocardial_t1 swine_model tachycardia-induced_heart_ failure
HFpEF ivabradine
PF_cohortNew_York_ Heart_associationSAF PF
diagnosis heart_ failure ED
Cardiac c-Kit_cells cardiac_explant-derived_ Cells cardiac_ functions myocardial_infarction
pathophysiology HF medical_management pathophysiologic
inhibitor jq1 BETs chromatin downstream_signalling RNA_ polymerase_ IIPol_ II
NPs pulmonary_embolism diabetes chemotherapy
empirically_ derived_composite_quality_ measure heart failureHF acute_Myocardial_infarctionAMI pneumonia pna
intestinal_ dysfunction disturbed_ intestinal_ barrier chronic_ inflammatory_ state catabolic_anabolic_imbalance cardiac_ cachexia CHF
heart failure preserved_ejection_fractionHFpEF
diminished_cyclic_adenosines_ monophosphate cAMP augmented_cyclic_ guanosine_ monophosphate cgm failing_hearts
mortality healthcare utilization_effects combinatied_care management telehealth congestive_heart failure chronic_obstructive_ pulmonary disease diabetes mellitus
catheter ablation atrial_fibrillationAF heart failure preserved_ejection_fraction hbfef
ischemic-hypertensive_ cardiomyiopathy angina inducible_myocardial_ischemia coronary_ arteries
RA methotrexate tNF_ antagonist non-biological_ disease antirheumatic_drug nbDMARD
cox_ proportional_ hazards_regression_modeling ie acute_ coronary_ syndromes coronary_interventions
sphingosines-1-phosphate_ receptor s1PR β1-adrenergic_ receptorβ1AR g-protein-coupled_ receptors heart
e-septal pcWP e/e_lateral e/e_mean
inappropriate_therapy atrial_fibrillation carvedilol metoprolol
gLS LVEF sa CV_ events echocardiographic_systolic AF
Bradycardia intravenous_metoprolol cardiac_ sympathetic_ tone CHF-inv rabbits sham-inv CHF-DNx
cPG-recommended_pharmacological_ treatment device_ consideration left_ ventricular_function_ assessment
Nordic_ walking standard_ cardiac rehabilitation_care functional_capaciteit severe_heart_ failure
Rad Q66p inhibitory_ actions Rad cav1.2 cav1.3 l-type_ channel isoforms heart
EF LCx LAD infarcted_ left_ ventricle LCx LAD
signalling cascades microRNAs bHLh transcription_ factor hand2 postnatal_ mammalian_ myocardium embryonic_ gene programs heart failure
ERC DAPc_ protein levels sarcomeric_ microstructure markers Skm growth myofibre_ regeneration
mva surgical_ ring_ implantation leaflet_ motion leaflet_ resection edge-to-edge_anastomosis
hART New_York_heart_associationNYha HF self-management_ counseling death HF
BET bromodomain_ proteinsBETs acetyl-lysine_ reader_ proteins HF
cardiac_function echocardiography diastolic_ dysfunction ejection_fraction
aldosterone_ antagonism heart failure aldosterone neurohormone electrolytes heart failure systolic_ dysfunction
EH LV_ compliance CHLV end-diastolic_ volume LV_ end-diastolic_ pressure β_coefficient
Grading_of_recommendations evaluatingGRADe practical_recommendations clinical
HF
right_heart circulatory_ failure mechanisms_of_ disease right_heart
l-type voltage-gated_ca(2+)_ channels ventricular_action_ potentials excitation-contraction ec coupling myocardium
AT1 receptors neprilysin blocks renin-angiotensin-aldosteronRAS vasodilatory diuretic_effect natriuretic_peptides
ivabradine exercise capacity left_ ventricular_ filling heart failure preserved_ejection_fractionHFpEF
blood transfusions iron erythropoiesis-stimulating_agent anemia congestive_ heart failure coronary_heart_ disease transfusion
bNP glomerular_filteration_ rate hypertension transmitral_e-waveearly_diastolic_metral_ annular_ velocity
β-blockade cAMP-dependent_ protein kinase pka β-adrenergic_ receptor activation
erythropoiesis-stimulating_agent_therapy
clinical genetic CHF_ predictive_model curveAUc geneticAUc clinicalAUc
black_race mortality hospitalizationhazard_ ratio h cardiovascular_ mortalityHF
percutaneous_ one-vessel_model chronic_Myocardial_ischemia stent polytetrafluoroethylene_ tube bottleneck
Centers_for_ Medicare_en_ Medicaid_ Services cms
heart failureHF tumor necrosis_ factorTNF tNF_ antagonists HF
signal transduction_ cascade transcription factors cardiomyocytes transcription factors epigenetic chromatin_ structure
cox proportional_ hazard_ models follow-up physician discharge death
AT peak_ oxygen_uptake metabolic_ exercise cardiac kidney index_ score HF index
mechanism annular_ size reduction surgery diastolic_metral_ valve tethering anterior_leaflet opening papillary_ muscles left_ ventricular_dilatation
hypertensive_hFPEF sodium-restricted_ DASh diet ventricular_ diastolic_ function arterial elastance ventricular-arterial_ coupling
CHF hCT polymorphisms anthracycline_ metabolism iron_ homeostasis anti-oxidant_defence myocardial_ remodelling
significant_regression_analyse severe_ CAD diameter_ stenosis left_main 3-vessel_ CAD proximal_ left_ anterior_ descending_ artery
heart failure acute_Myocardial_infarction acute_Myocardial_infarction Western_Australia
Randomized_aldactone_evaluation_ Study symptomatic_ chronic_heart_ failure aldosterone antagonist spironolactone mortality
medication nonadherence salt intake
pathophysiological
lVAD albumin_ levels hypoalbuminemia surgery
scientific_ literature HM_ II HeartWare_ patients economische hm_ II
creatininehazard_ ratio post-transplant mortality
complications implantation lVAD_therapy transplantation eligibility_status device bTT DT medical_therapy
radial_ artery_ tonometry pICU
HR variability_turbulence HR variability_turbulence cardiac_ patients
dopamine nesiritide renal_function acute_heart failure renal_ dysfunction
glomerular_filteration_ rateodds_ ratio confidence_ interval
breast_cancer patients full_ Medicare coverage stage_ I-III_ breast cancer chemotherapy sEER-Medicare Texas_cancer Registry_Medicare databases
eRK1/2 signalling signalosome_ complex scaffold_ protein kinases sequential_phosphorylation effector_ molecules
magnetically_levitated centrifugal-flow_ chronic_ lVAS
diseased_ cardiomyocytes pde2 activity cgMP nitric_ oxide donors pde2 inhibition β-AR_ responsiveness
ejection_fraction natriuretic_peptide heart_ failure inhospital_ outcomes get_met_the_guideline_heart_ Failure_ Registry
beta1-adrenergic_ receptor sphingosine-1-phosphate_ receptor s1PR cardiac hypertrophic_ response heart failure s1PR1 cardiac_ gene therapy
ecs HDl phosphorylation eNOS-Ser eNOS-Thr PKc-βII-Ser p70s6k-Ser
rCTs sts h h m m ss ss sts TM
mouse ventricular_Myocytes sarcomere
administratie_ databases Alberta discharged_ alive_van_hospital heart failure
pasp
cRT_on_ assignment time_to_ death HF_hospitalizationhazard_ ratio LVEF
heart_ failure myocardial_ collagen tissue control heart failure
l-dko_mice cardiac_ IRS1 iRS2_ proteins heart_ failure cardiac_energie_ metabolism p38α mitogen-activated_ protein kinase
nicorandil doxorubicin-induced_heart failure rats hemodynamic_ perturbations mitochondrial_ dysfunction ultrastructural antitumor activity
Rhythm_control_therapy af atrial_ structure sinus rhythm delayed_rhythm_control
relative_risk_van_heart_ failure bisphophonates crude_RR confidence_ interval CI adjusted_ hazard_ ratioHR
physician adherence guideline_ recommendations heart_ failure Clinical_ Practice_ Guideline pg heart failureHF
acute_heart failure renal_ dysfunction dopamine nesiritide renal_function diuretic_therapy
HF body_ composition skinfold_ thickness dual-energy_x-ray_ absorptiometry echocardiography blood
hoog-cost_ Medicare fee-for-service Centers_voor_ Medicare Medicaid_ Services
hospitals heart failureHF acute_Myocardial_infarction pneumonia
heart_ failure
kccq summary_ scores New_York_heart_association HFpEF HF EF
aCP restrictive_ red_ blood_ cell_ transfusion_strategietrigger_ hemoglobin_ threshold hemoglobin_ levels coronary_ heart disease
implanted left-to-right_interatrial_ shunt haemodynamic heart failure ejection_fraction
Caloric_restriction aerobic_ Exercise Training Peak_oxygen_ Consumption Heart Failure Preserved_ejection_fraction
left_ ventricular_assist devices lVADs chronic_ end-stage_heart_ failurebridge_ to_ transplantation bt transplant-ineligible patients destination_therapy dt
right_ ventricular-pulmonary_ arterial_ couplingpulmonary_ vascular_ resistance right_ ventricular_ejection_fraction
carvedilol metoprolol implantable_ cardioverter-defibrillator therapy MADit-cRT multicenter_automatic_deibrillator Implantation Cardiac_resynchronization Therapy
Oral_ glucocorticoids HF
HR ivabradine_groep Ea TAC
HFPSI risk_of_ death medical_hospitalization HF_ clinic_outpatients HF
CHm adjunctive_ treatment dCM heart failure
carvedilol inappropriate_therapy metoprololhazard_ ratio cri
testosterone_ supplementation exercise rehabilitation CHF low_ testosterone_status
VO2 lean_ body_ mass thigh_ muscleintermuscular_ fat_ ratio
get_met_the_guidelines-heart_ Failure HFEF borderlineEFEF preservedEFEF EF
multivariate_cox_model_analyse pasp exercise haard_ ratio pasp
cardiac_ insulin-resistance mitochondrial_ oxidative_ metabolism cardiac_ hypertrophy energy deficit hypertrophy heart failure
rGK rem rem2 rad gem_Kir monomeric_g_ proteins ventricular_action ec_ coupling cardiac l-type_ channel activity
mechanism annular_ size reduction surgery diastolic_metral_ valve tethering anterior_leaflet opening papillary_ muscles left_ ventricularLV dilatation
pathophysiology heart failure preserved_ejection_fraction hbff myocardial_extracellular_ matrix accumulation
breathing_control cardiac_ arrest pulseless_ ventricular_fibrillationPVf cardioverter-defibrillator_ device
n-terminal_probNP nt-probNP midregional_proANp m-proanp total_ adiponectin CHF bMI FM
acetylcholinesterase inhibitor pyridostigmine sympathovagal_ balance cardiac_ remodeling cardiac_ function HF myocardial_infarction
cardiac_ sympathetic_activiteit i-meta-iodobenzylguanidine i-MIBG β-blocker
Swedish_web-system_voor_enhancement_ and_ Development_of_evidence-based_care Heart_ disease Recommended_therapies_ registry caBG Sweden
LVEF clinical_composite_ response reverse_ remodeling_ parameters time_to_ death HFhazard_ ratio
brain natriuretic_peptide bNP bNP
pde_superfamily pde2 cgMP cAMP hydrolysis negative_cross_talk cgMP cAMP_signaling
tAPselongitudinal_RV_ fiber_shortening paspforce in vivo_RV length-force_ relationship
mitochondrial-targeted_ antioxidant Szeto-schiller s20 cardiac_ function proteomic_ remodeling signaling pathways
Tools_voor_economic_analysis_of_ Patient Management_ Interventions_in_ Heart_ Failure_ Cost-effectiveness_model disease management programs heart failure
re-hospitalization admissions
coprimary cumulative_ urine volume decongestion_ end point serum cystatin_c enrollmentrenal_function
cardiac_ arrest cardiopulmonary_reuscitation cPR posterior_ wall_infarction cardiac_centre
diabetes saxagliptin sitagliptin pioglitazone sulfonylureas long-acting_ insulin products
hyperkalemia mineralocorticoid_ receptor_ antagonists race mineralocorticoid_ receptor_ antagonists heart_ failureHF
aCP erythropoiesis-stimulating_agent anemia congestive_heart failure coronary_heart_ disease
heart failureHF ejection_fractionrEF renin-angiotensin_systemRAS β-blockers
uPR scn5a ventricular_ systolic_HF_ tissue samples induced_ pluripotent_ stem cell-derived_ cardiomyocyteshiPSc-CMs
coPD CHF cRF ICC kappa coefficients
implantable_ cardioverter-defibrillator deactivation implant
heart failure left_ ventricular_ejection_fraction aerobic_training_ period integrated_dynamic_ resistance_training lower_ limbs
heart failure myocardial_ function dilated_ver contracting ventricles
cochrane_ Effective_ Practice organisation_of_care_ Taxonomy
mouse_rad Q65p murine_ equivalent_of_human_rad Q66p l-type_currents cav1.2 cav1.3 wild-type_Rad
implantable_ cardioverter-defibrillator deactivation distressing implantable_ cardioverter-defibrillator_ shocks
mouse_ heart failureHF model hypertensive_heart_ disease hHD pathophysiology hHD
MI_karakteristics hazard ratios HF
Medicare patients acute_care_hospital HF AMI pna
ctnt NT-probNP aRIC_HFAUcs continuous_ NRIs
cardiovascular_ events sst2 BB_ dose metoprolol_ succinate
EC HDlNYha-IIIb phosphorylation eNOS-Ser phosphorylation eNOS-Thr HDl
patients hospitalized HF LVEF LVEF LVEF
sarcoplasmic_ reticularSR ca(2+)-uptake protein_ content SR ca(2+)-pump phospholamban infarcted_hearts metoprolol
global_ left_ ventricular_ longitudinal_systolic_ strain gLS left_ ventricular_ mechanics cardiovascularCV atrial_fibrillationAF
early-onset late-onset HF HF HF HF EF HF HF HF_met_ preserved_ EF mix HF HF MI
carvedilol Willebrand_ factor metoprolol β2-adrenergic_ receptor haplotype
exercise intramuscular_ testosterone_ supplementation chronic_ heart failureCHf low_ testosterone status
heart failureHF plasma natriuretic_peptide bNP preserved_ejection_fraction ejection_fractionEF HF
gLS left_ ventricular_ejection_fractionLVEF systolic_metral_ annulus_ velocity sa CV
RM home_monitoringTM implanted_monitoring devices medical_support structured_ telephone_support ss human-to-human contactHH human-to-machine interface hm
Timed_up_go tug chronic_obstructive_ pulmonary diseasecoPD chronic_ heart failureCHf chronic_ renal_ failurecrf
cox_regression_analyse beta-blockers beta-blockers inappropriate antitachycardia_ pacing aTP shock_therapy
ethically_ complex pediatrics families religious_ beliefs life-sustaining_ treatment legal_ majority
commissie guideline-recommended_ medications medical records performance_ measurement
kosten rhythm-control rate-control
median_ age women median_ left_ ventricular_ejection_fraction median_egFR
cd34_vegFR2+ cells functional_ capacity 10-cell cd34_vegFR2+ cells
fit unfit cRF hazard ratios fit unfit overweight_ body_ mass index obese_men
Medicare_ Patient_ Safety_monitoring_system mSMS adverse_event_ rates acute_Myocardial_infarction congestive_heart failure pneumonia surgery
HFPSI blood urea_ nitrogen natriuretic_peptide New_York_ Heart_association diabetes atrial_fibrillationflutter
cRT_groep hazard_ ratio 95%_ confidence_ intervalCI
concurrent_HF concurrent_HF case-fatality_ rate
inpatients heart failure reduced_ejection_fraction treatment
CHF anthracycline stem cell_ sourceallogeneic autologous follow-up
resting_ tension fpassive_-sarcomere_leng relations muscle strips kcl-KI treatment titin extracellular_ matrix fpassive
aerobic_en_ resistance_training_ intervention augmented_ feedback exercise capacity muscle_ strength cardiacNT-probNP inflammatoryIL6 hscrp biomarkers
readmission acr Potential_prevenentable_ Readmission pPR Centers_voor_ Medicare Medicaid 30-day_ readmission cms
heart failure myocardial_infarction m β-adrenoceptor_blockade infarcted_ rats metoprolol
Minnesota_kwaliteit_of_ life exercise_groep
congestive_heart_ failure_ visits ED
arginine_ vasopressin aVP CHF aVP vasopressin_ receptor_ antagonist_therapy CHF
medication physical_therapy implantable_defibrillators circulatory_support transplantation heart failure therapies disease
rats hearts excised caspase-3 activity phosphocreatine adenine_ nucleotides cytochrome bcl2 Bax caspase
rapid_ right_ ventricular_pacing Bax bcl-2 Caspase-3 RTq-PCr interventricular_ septum biopsies beagle_ dogs heart failure
anginiotensin-converting_ enzyme inhibitorsangiotensin_ receptor_blockers β-blockers heart failure ejection_fraction
sodium-restricted_ dietary_ approaches hypertension dietDASh srd left_ ventricular_ diastolic_ function arterial elastance ventricular-arterial_ coupling hypertensive_hFPEF
acute_HF RELAx-aHF ASTRONAUT PRONTO patient enrollment patients
metoprolol carvedilol sympathetic_activiteit von_Willebrand_ factor arg16 gln27 gly16 glu27
HF international_ Classification_of_ Diseases Ninth_revision Clinical_ Modification codes discharge
Rad Q65p gating_ movement wild-type_Rad Q65p l-type_ channel inhibition rGK_ proteins
heart failure proteomics actin_ cytoskeleton_ pathways SS20 mitochondrial metabolic_ pathways
echocardiograms left_ ventricular_ base midpapillary apex baseline IVc occlusion BiVP STE twist apical basal rotations CS RS synchrony
pyridostigmine coronary_ artery_ ligation cardiac vagal sympathetic_ tone cardiac remodeling left_ ventricular_ dysfunction HF
New_York_ Heart_associationNYha Class_ II_ Heart_ Failure eplerenone Placebo standard_ Heart_ Failure MedicinesEMPhaSIS-HF
discharge follow-up
heart failure refractory terminal_heart failure
heart_ failure_ discharges University_of_ Connecticut_health Center
Pulmonary_capillary_ wedge_ pressure hg sd right_atrial_ pressure pulmonary_ arterial_ pressure pulmonary_ resistance
acute_heart_ failureHF pharmacologic_studies calcium-sensitizing_agent endothelin vasopressin adenosine
aortic_insufficiencyAI mechanical_ circulatory_support continuous_ flowCF left_ ventricular_assist devices lVADs pulsatile_ devices
in vivo_experiments HF induced mice phenylephrine haemodynamic_stress transverse_aortic_constrictionTAC jq1 cardiac_ hypertrophy
drugs RAas direct_renin inhibitors neutral_endopeptidase_ inhibitors vasopeptidase inhibitors angiotensin_ receptor_blockers
pde2 overexpression cardiomyocytes cAMP ca2 inotropic β-AR_stimulation basal_contractility
bottleneck_ stent proximal_ left_ anterior_ descendingLAD proximal_ circumflex_ artery lx proximal_LCx mid_LAD
acute_miocardial_infarctionAMI heart failureHF complicatingAMI
i-miBG cardiac_washout carvedilol metoprolol β2-adrenergic_ receptor haplotype
muscle_ aerobic_ capacity postexercise_phosphocreatine_resynthesis Fontan adults
Cardiac_resynchronization_therapy cRT dialysis-dependent_ patients heart failureHF cRT dialysis
eplerenone hyperkalemia renal_ function EMPHASIS-HF eplerenone_in_ Mild Patients Hospitalization SurvIval Heart Failure
h-dko ventricular_ mass cardiac_ apoptosis fibrosis Akt_forkhead_ box o-1 cardiac_ metabolic_ gene expression ATP
inappropriate_ ATP inappropriate_ shock_therapyHR
cardiorespiratory_ fitnesscrf body mass index heart failure HF cardiovascular_risk factors HF_ mortality fit unfit_ men
postmarketing_ trials hospitalized_heart_ failure hHF dipeptidyl_ peptidase-4 dPP-4 inhibitors antihyperglycemic_agent
cox_modeling Heart_ Failure_ Patient_ Severity_index hPSI University_of_ Michigan HF_ clinicum_cohort
Heart rateHR cardiac_ patients acute_ myocardial_infarctionAMI congestive_ heart failureCHf left_ ventricularLV
neonatal_ rat ventricular_ cardiomyocytes chronic_ insulin exposure iRS1 iRS2_ proteins insulin action cardiac_ dysfunction insulin resistance type_ diabetes
echocardiograms left_ ventricular_midpapillary level atrioventricular_delay vd interventricular_delay vd ste circumferential_ strainCS radial_ strainRS
New York_ Heart_associationNYHA functional_class_ III HF ejection_fractions chronic_ stable_ guideline-directed_ medical_therapyGDMT
non-LBbb QRs
pka_subunits type_ II_ regulatoryRIiα catalytic cα rIIα ser96) cα phosphorylation HF
abnormal_ca(2+) handling dyssynchronous_HF myofiber shortening_ velocity septum depresses myofiber shortening stretch_ rate lateral_wind
CHF-derived c-Kit_+ cells transforming_ growth_factor-β tGF-β epithelial mesenchymal_ transition_ markers pluripotency_ markers shams
label-free_shotgun proteomics transverse_aortic_constrictionTAC-induced_heart_ failure
hFrEF left_ ventricular_ejection fraction HFpEF left_ ventricular_ejection fraction RAS- β-blocker index HF
activation p70s6k PKc-βII malondialdehyde HDl nyha-IIIb
g-protein-coupled_ receptors reciprocal_regulation mouse_ hearts chronic β-adrenergic_ receptor_stimulation postischemic_heart_ failure
Body_gewichtSD diet_groepSD exercise_groepSD diet_groepSD
NT-probNP inflammatory_ biomarkers hscrp IL 6 hscrp
ejection_fraction frail biological_ phenotype frailty deficit index
resting_HR
tGF-β_ inhibition c-kit_+_ cell_ phenotype cardiac_ progenitor function cell_expansion
BETs neurohormonally_ induced_heart disease nanomolar_ doses jq1 phenylephrine-mediated_ hypertrophy cardiomyocytes pathological_ gene induction
concentric_ remodelingcr concentric_ hypertrophyCH left_ ventricularLV heart failure preserved_ejection_fractionHFpEF eccentric_ hypertrophyEH
BAT nc-terminal_pro-brain_ natriuretic_peptide burden heart failure hospitalizations gm-treated_ NYHA functional_class_ III HF
MLHF_Total_ score exercise diet
nonpace non-DNx sham-Innervated sham-inv nonpace DNx sham-DNx pace non-DNx cmf-inv pace DNx cmf-DNx
Exercise_ time pss pss btes
hemoglobin hgb HRQol HRQol Heart Failure Exercise_trainingHF-acTION
RV_ dysfunctionhazard_ ratio confidence_ interval ci cachexiahazard_ ratio ci
Atrial_fibrillation congestive_ Heart_ Failure Québec rhythm rate-control_ treatment
calcineurin nfat_signalling mir-25_expression helix-loop-helix bHLh transcription factor dhand hand diseased human mouse_ myocardium
heart failure myocardial_ischaemia bradyarrhythmias valvular_regurgitation pulmonary_embolism infection renal dysfunction
hABC_ Battery_ score HF_risk Health ABC_HF_model h hb HF_model SD controlled_for_ death competing_risk h
NT-probNP cutoff_point sensitivity confidence interval curve
prognostic_power r-r_ interval_oscillations non-linear_HR_ variability_ measures short-term_fractal_ scaling_ exponent
heart failureHF ventricular_tachycardia HFVT VTHFVT structurally_normal_ hearts hNorm
gLS cox_model chronic_heart_ failure hypertension diabetes prior_stro score glomerular_filteration rate LVEF sa CV
diastolic_function diastolic_ filling_ formalism relaxationviscoelastic passive_stiffness doppler_metral_inflow_ velocity e-wave
VAD ventricular_assist_ device_support ecmo extracorporeal_ membrane_ oxygenation_ membrane_support ecmo ecmo VAD
mt NYha HFpEF hFrEF HFpEF HFpEF HF_hospitalization
heart_ failure_ disease management
resistin heart failure humanized_ mouse murine_ resistin transgenic Retn_ gene hum-retn_mice inflammation-stimulated_ resistin humans
angiotensin-converting_ enzyme inhibitorsangiotensin_ receptors blockers β-blockers devices
TTA tgtetMena_mice cardiac_ injury ejection_fraction fractional_shortening heart dilatation hypertrophy transverse_aortic_constrictionTAC
heart failure_ patients Italy confirmatory_factor_analyse cfa SCHfi Self-Care_ Maintenance Self-Care_management Self-Care_ Confidence
resynchronization-Defibrillation ambulatory_ Heart_ Failure trial implantable_ cardioverter_defibrillator-cRT mortality heart failure
ischemic_ eventsIEs ischemic_ cardiomyopathy iic cardiac resynchronization therapy defibrillator cRT-d
renal dysfunction chronic_obstructive_ pulmonary disease diabetes peripheral_vascular_ disease left_ ventricular_ejection_fraction iCD shocks ischemic_ cardiomyopathy male_sex
CHF SD_ testosterone
Raf-MEK1/2-erk1/2_scaffold_ proteins cardiac_ remodelling therapeutic
functional_ MS LV dilatation treatment_for_ heart failure HF LV functional_ MS HF HF MR degenerative_metral_ valve
angiotensin converting_ enzyme inhibitor angiotensin-receptor blockers β-blockers heart failure medications
New_York_ Heart_association kccq overall_ Summary symptom_ domains Spearman_ correlations 2-way_aNOVA patients HF EF HFpEF
LV systolic_ indicesLV ejection_fraction LV strain_ rate systole diastolic_ indices LV strain_ rate diastole early_ transmitral_ flow sinus rhythm follow-up
c57BL ANG_ II_infusionAT ANG_ II_infusion uninephrectomy ANG_ II_infusion salt_ loading as ANG_ II_infusion uninephrectomy salt_ loadingANS
early_ transmitral_ blood_ flow_ velocity doppler early_diastolic_metral_ annulus_ velocity pulmonary_capillary_ wedge_ pressure pcp decompensated_ systolic_ heart failureHF
VO2 exercise mL/kg_ body_ mass
AMI hospital best_ quintile_of_ performance Hospital_ Compare
kccq HFpEFlog_ rank EF
ctnt NT-probNP ctnt NT-probNP HF
Mass_spectrometry circulating NT-probNP physiological_proteolysis leu3-gly
HFpEF New_York_ Heart_association mean_ejection_fraction
depressed_ left_ ventricularLV systolic_ pressure pressure ejection_fraction fractional_shortening cardiac_ output LV_ end-diastolic_ pressure MI animals metoprolol
baroreflex_activation Therapy Heart_ Failure Reduced_ejection_fraction carotid_ baroreflex_activation_therapyBAT advanced_heart_ failureHF
enrollment_ periodhazard_ ratioHRHR
HF raised_ blood glucose_ levels obesity tobacco systemic_ hypertensionSH rheumatic_fever Chagas_ disease c'd
age- sex-adjusted_risk hazard_ ratios ci early-onset_HF ci late-onset_HF
cRF overweight obese_ body_ mass index
egFR egFR groep_ III egFR uncontrolled_ hypertension diuretics age ESRD
myocardial_phosphodiesterase-2 pde2 heart failureHF beta-adrenergic_ receptorβ-AR cardiomyocytes
heart failure cardiac_resynchronization_therapy defibrillator implantable_ cardioverter-defibrillator_ device carvedilol ATP shock_therapy metoprolol
epicatechin-rich_ cocoa Skm mitochondrial_ structure taub ramirez-sanchez ciaraldi perkins ciaraldi perkins Murphy naviaux Hogan ceballos maisel Henry
follow-up_ visits death urgent_ readmission physicians
mena overexpression TTA tgtetMena_mice TAC_ surgery cardiac_ hypertrophy TTA tgtetMena
PD diuretic_refractory severe-end-stage_HF
ATP mitochondrial_ oxidation glucose lactate fatty_ acids myocardial_ glycolysis
proangiogenic_effect b activation_van_veGF_ pathway adenoviral_vector decoy_veGF_ receptor ad-flk adenovirus ad-c treatment
eplerenone potassium potassium hyperkalemia medication
bottleneck_ stent proximal_LAD llcx reversible_myocardial_ischemiaopen_ stent ischemic_heart_ failure ocluded_ stent
New York_heart_association_ class_ III_heart_ failureHF left_ ventricular_ejection pb permanent_ periodic_ breathing pb
potassium spironolactone non-AAs AAs race
symptom_ limited_cPET CHF exercise exercise
echocardiography LV end-diastolic_ volume MR mitral_ valve mVA pressure gradient
post-LVAD_AI aortic_valve oversewing leaflet repair bioprosthetic_aortic_valve_ replacement CF lVAD AI
systolic_heart failure β-blocker angiotensin_ converting_ enzyme inhibitor angiotensin-receptor_blocker
exercise-induced_ pulmonary_ artery systolic_ pressurePASp stress doppler_echocardiography right_ ventricular_contractile reserve pulmonary_ hypertension right_ heart failure
MEDlineEMBAse healthstar cINAHL cochrane_ Library Campbell_ Collaboration Joanna_ Briggs Institute_voor_reviews_ and Dissemination evidence_based_practice Centres
heart failure neuro-hormonal_systeem angiotensin_ converting_ enzyme inhibitorsangiotensin_ receptor blockers angiotensin_ converting_ enzyme inhibitors intolerance beta_ receptor blockers mineralocorticoid_ receptor antagonists
open_ chest_model twist RS RS synchrony CS STE rvpo RS synchrony CS BiVP
tAPse pasp tAPse-to-pasp_ ratioTAPSe_pasp cox_ regression kaplan-meier_analyses tAPse pasp
obeseSD body mass index chronic_ stable_hFPEF
human_heart_ failureHF mRNA splicing voltage-gated_ cardiac_na+_ channel α-subunit scn5a encoding truncated nonfunctional_ channels endoplasmic_ reticulum
paediatric_heart_ failure myocarditis dilated_ cardiomyopathy heart failure anthracycline childhood malignant_ disease
Tools_voor_economic_analysis_of_ Patient Management Interventions_in_ Heart_ Failure_ Cost-Effectiveness_model
natriuretic_peptidesNPs b-type_NP n-terminal_ pro-b-type_NP acute_heart_ failure Emergency_ DepartmentED acute_ dyspnea
peak_ oxygen_ consumption VO2ven vco2 slope exercise oscillatory_ ventilation eOV partial_ pressure end-tidal_co2PETco2 cardiopulmonary_ exercise testing
danes bisphosphonates raloxifene
longitudinal_ strain left_ ventricle echocardiographic_ measurements baseline_echocardiography cRT follow-up_echocardiograms
hypertension LV dilatation LV dysfunction m m mitral_ valve organic_ lesion systolic diastolic_tethering functional_ etiology MR MS
HDl healthy_controlsHDl CHF-NYha-IIIHDl nyha-IIIb ET CHF-NYha-IIHDl nyha-II
platelet-activating_factor pbf metabolic_ enzymes heart failureHF
acute_care_ surgeryacs oHT transplantation medical_therapy m intravenous_inotropes ventricular_assist devicesVADs
renin-angiotensin-aldosterone systemRAas hFrEF angiotensin-converting_ enzyme inhibitors angiotensin_ receptor blockers aldosterone_ blockade HFpEF
HFpEF ivabradine left_ ventricular_ filling_ pressure exercise diastolic_metral_ flow_ velocity diastolic_metral_ annular_ velocity
lVET unfavorable_ outcome milliseconds tonometric_ indices
heart rate blood pressure renal_ function spironolactone RAS_blockers β-blockers
cardiac performance β-adrenoceptor_blockade heart_ failure SR_ca(2+)-pump_ function reverse_ cardiac_ remodeling plasma_ catecholamines
SS31 congestive_heart_ failure mitochondrial_ damage TAC mitochondrial_proteome_ changes mitochondrial nonmitochondrial_ protein
HF-action exercise_training HF low_ left_ ventricular_ejection_fractions HRQol Kansas City_ Cardiomyopathy Questionnaire kccq
tolvaptan hyponatremia Japan congestive_heart failure diuretic_therapy serum sodium levels systolic_ function
mijnofibrillar ca(2+)-stimulated_ ATPase mRNA levels SR ca(2+)-pump phospholamban α-myosin_ heavy_ chain mRNA mRNA β-myosin_ heavy_ chain metoprolol
anesthetized_dogs coronary_ microembolization-induced HF cXL-1020 left_ ventricular_ end-diastolic_ pressure myocardial_ oxygen consumption ejection fraction maximal_ ventricular_power index
heart_ failure contrast_agent
mDC 95%_ confidence level mDC mDC 95%_ confidence level mDC
etiologies HF la idiopathic dilated_ cardiomyopathy c'd ischemic SH valvular alcohol
ST2 functional_ capacity ambulatory patients HF Heart_ Failure trial_ Investigating_outcomes Exercise_ Training HF-acTION exercise_training HF
carvedilol metoprolol inappropriate_ implantable_ cardioverter-defibrillator_therapy MADit-cr multicenter_automatic_deibrillator Implantation_ With_ Cardiac_resynchronization Therapy
angiotensin-converting_ enzyme inhibitorsangiotensin_ receptor_blockers therapy β-blockers therapy
ischemic_HF NYHA glomerular_filteration_ rate heart rate hypertension diabetes mellitus myocardial_infarction
cRT systolic_ dysfunction resynchronization reverses_remodeling systolic_ left_entricular_ dysfunction reverse left_ ventricularLV ejection_fractionLVEF
signaling paradigms β1ARs s1PR1s myocyte cAMP_ production receptors g-protein-coupled_ receptor kinase-2
follow-up PAf-cpt PAf-at lyso-paf-at paf-AH lp-PLA2
diagnosti performance s'lateral aUC s'lateral aUC
Rate-control patients cardiac_procedures cardioversions kosten antiarrhythmic_ drugsCAD confidence_ interval CI
spironolactone
diabetes mellitus cardiomyopathy β-blocker angiotensin-converting_ enzyme inhibitor angiotensin_ II_ receptor_blocker
eplerenone post_myocardial_infarction_ Heart_ failure SUrvival e euras post-myocardial_infarction heart failure mortality aldosterone antagonist eplerenone
cardiopulmonary_ exercise_ testing_ guide exercise rehabilitation chronic_heart_ failure chronic_heart_ failureCHf CardioPulmonary_ Exercise_ Testing cPET exercise rehabilitation
risk reductionHR heart failure-related_ mortality sudden_ death HR
DASh srd brachial_systolic_ pressure central_en-systolic_ pressure
HF LVEF Heart Failure_ Survey israel
HF obese body mass index black_ ethnicity idiopathic-dilated_ cardiomyopathy
left_ ventricular_ejection_fraction world_health_ Organization idiopathic_ dilated_ cardiomyopathy negative_ coronary_ angiography
europese_socie_of_cardiology hFPEF heart failure LV ejection_fraction non-dilated_ left_ ventricle diastolic_ dysfunctionimpaired_ LV_ relaxation LV diastolic_ stiffness LV filling_ pressures
glomerular_filteration egFR diabetes total_ cholesterol lDL-cholesterol CLcnka_gg genotype
echocardiography LV end-diastolic_dimension LV end-diastolic_ pressurewall_ stress lung_ weight untreated_aCF sham_groep
heart failure ejection_fraction standard_ cardiac_ rehabilitation_care Nordic_ walking
dRS-stratified_ hazard_ ratios ci sitagliptin pioglitazone sitagliptin sulfonylureas ci sitagliptin insulin
skeletal_ muscle_massa t-score figuur sarcopenic_ range_ muscle_wasting t-score
RAS- β-blocker_uptitrations all-cause_ mortality HF_ readmissions hFrefhazard_ ratioHR confidence_ interval ci
testosterone_groep peak_ oxygen_uptake Beck_depression_inventory leg_ strength Medical_outcomes Short-Form_ quality_of_ life
Heart_ Failure controlled_trial_ Investigating_outcomes_of_ Exercise_trainingHF-action social_ support_ score pss barriers_ to_ exercise_ score btes
ST2 cardiovascular_ death HF_hospitalizationhazard_ ratio all-cause_ mortalityhazard_ ratio hazard_ ratios log2
New_York_heart_association_class_ I_fontan_ adults cardiopulmonary_ exercise lean_ mass_ quantification dual_ x-ray_ absorptiometry dXA calf_ muscle magnetic_reonance_spectroscopy
dopamine nesiritide diuretic_therapy renal_function acute_heart_ failure renal_ dysfunction
ncord_heart_association heart failure left_ ventricular_ejection fraction QRs echocardiographic left_ ventricular_ dyssynchrony
left_ ventricularLV ejection fraction HF right-sided_ cardiac_ catheterization transthoracic_echocardiography transmitral_ flow_ velocities mitral_ annulus velocities systole diastole
acute_ coronary_ syndromes CAD bNP NT-probNP CAD
HF lyso-paf-AT PAf-cpt PAf-AH lp-PLA2
redo_sternotomy aortic_valve bioprosthetic_valve_ replacement dacron_ patch_closure aortic_ valve transcatheter aortic_ valve procedure open_ surgery aortic_ valve_ replacement
cutoff_waarde plasma_n-terminal_pro-b-type_ natriuretic_peptideNT-probNP acute_heart_ failureHF emergency_ departmentED
cardiac_ troponin_t ctnt high-sensitivity assay n-terminal_pro-b-type natriuretic_peptident-probNP incident_HF HF HF Atherosclerosis_ Risk_in_ CommunitiesARIc
body_ mass indexHR_per_ kg/m_index fat-free_ mass_ index
figuurinterquartile_ range median_ body_ mass indexinterquartile_ range advanced_ COPd CHF cRF
reverse_ remodeling ejection_fraction mortality HF dialysis_ patients
EH LV_ contractility CH LVEF systolic_ blood_ pressure end-systolic_ volumeβ coefficient
echocardiography dilated LV end-diastolic_ volume index mL/m2 LV ejection fraction mild_ MR mitral_ valve opening MS mVA pressure gradient
renal_optimization_strategies_evaluationROSe acute_heart_ failure renal_ dysfunction glomerular_filteration_ rate
BETs chromatin-mediated_signal transduction Pol_ II co-activating_ transcription_ factor_ networks HF nuclear_factor activated_t_ cells nFAT nuclear_factor-κbNF-κb transcription_ factor gATA4
guideline cardiovascular_ events myocardial_infarction congestive_heart failure arrhythmia cardiac_ death hypertension venous_thromboembolic_ events ischemic_ cerebrovascular_ events
EO-cFUs diabetes 10-EO-cFU EO-cFU VO2 diabetes diabetes EO-cFUs
cardiovascular_ mortality hazard_ ratio
immunoblotting radioenzymatic- fluorescence_ resonance_energy_transfer-based_assays video edge_ detection epifluorescence_ microscopy l-type_ca2 ca2 myocardial_ tissues cardiomyocytes HF
Exercise_ capacity peak_ oxygen_ consumptionVO2 ml/kg/min QOL Minnesota Living_ with_ Heart_ Failure mHF heart_ failure-related_ QOL
east Atrial_fibrillation_for_stroke_ prevention_trial AF_at_risk_for_strokeCHA2ds2VASc
low_ left_ ventricular_ejection_fraction HF preserved_ left_ ventricular_ejection_fraction hospital physicians
TAC-induced_proteomic_ alterations mitochondrial-targeted_peptide SS31 perturbed_ mitochondrial_ function TAC mitochondrial-targeted_peptide drugs heart failure
HF thorEF preserved left_ ventricularLV ejection_fractionHFpEF echo-Doppler studies natriuretic_peptide
low-volume_EDs comorbidities hospitalized medium aOR confidence_ interval high-volume_ EDs aOR
hABC_battery_ scores health ABC_HF_risk_model discrimination c-index reclassification-improvement HF
cardiac_ transplant ecCT diabetes mellitus chronic_ kidney disease glomerular_filteration
cfi RMsea Self-Care_ Maintenance_ Scale cfi RMsea Self-Care_management_ Scale cfi RMsea Self-Care_ Confidence_ scale
BAT quality-of-life score NYHA functional_class_ ranking
hypoalbuminemia postoperative_normalization albumin levels hypoalbuminemia decreasing_albumin_ levels lVAD
rehospitalization acute_miocardial_infarctionAMI kidney infection urinary_ tract infectionUTI
heart failureHF ischemic nonischemic_ cardiomyopathies pharmacological_armamentarium implantable_ cardioverter_defibrillators cardiac resynchronization therapy cardiac transplantation left ventricular_assist devices
SAF PF_ mean_ catheterization central_venous_ pressure hg sVR_ index dyn_ s/cm(5)/m(2) cardiac_ index
women admission median_bNP_ levels reducd_ef preserved_ EF median_bNP_in_ women_ vs_ men EF
heart failure_admission heart transplantationLV_assist_ device deathhazard_ ratio
ejection_fraction velocity circumferential_shortening systolic_ elastance contractile_ efficiency acf allopurinol rats maximum_o2 consumption_ rate isolated_ cardiomyocytes extracellular_ flux_ analyzer
HFpEF LV_geometry LV hypertrophy vh relative_wind_ thickness rwt CR vh rwt eh vh vh rwt
lCZ696 angiotensin_ receptor neprilysin_ inhibitor neprilysin_ inhibitor neprilysin_ inhibitor prodrug angiotensin_ receptor antagonist valsartan hypertension heart failure preserved_ejection_fraction heart failure_met_ reduced_ejection_fraction
blood pressure mitral_valve_plasty degenerative_ MR chordal_ ruptures triangular_reection edge-to-edge_anastomosis ring_ annuloplasty Physio_ RingEdwards_ Lifesciences irvine
shuttle_walk_ test peak_ oxygen_uptake muscular_ strength echocardiographic natriuretic_peptide inflammatory_ markers depression beck_depression_inventory minnesota_ Living_ with_heart_ Failure_ Questionnaire Medical
evaluate_term_analyse LVEF significante_reducingd_ LVEF long-term_ mortality preserved severely_reducingd_ LVEF
westar-kyoto lean_zSF obese_zSF obese_zSF zSF high-fat_diet metabolic renal echocardiographic hemodynamically euthanization
kaplan-meier_ curves log-rank_ testing
multivariate_cox_regression_analyses AF_type hypertension sinus rhythmhazard_ ratioHR confidence_ interval ci
chronic_HF-ref NYHA functional_class_ II egFR potassium eplerenone hyperkalemia wRF
fFM fm body_ fat distribution dual_energie_ X-ray_ absorptiometry dXA non-diabetic_ patients chronic_ heart failurecccc non-cachectic_ CHF myocardial_infarction-both
spironolactone HFhazard_ ratio AAshazard_ ratio
invasively pulmonary_ arterial_ hypertension inoperable chronic_thromboembolic_ pulmonary_ hypertension right_ ventricular_pump pulmonary arterial_ hypertension medication stress echocardiography cardiopulmonary_ exercise
cardiovascular_ death HF_hospitalization btes cardiovascular_ death HF_hospitalization exercise_groephazard_ ratio
index_ed_ visit low-volume_ed_ cases death_all-cause_ readmission medium aOR high-volume_ EDs aOR
implantable_ cardioverter-defibrillator_deactivation implantable_ cardioverter-defibrillator_deactivation
Cardiac_ magnetic_ resonance left_atrial_ areahazard_ ratio 95%_ confidence_ interval pulmonary_ vascular_ resistancehazard_ ratio 95%_ confidence_ interval cardiac
HF systolic left_ ventricular_ejection_fraction HF New_York_ Heart_association echocardiographic cardiopulmonary_ exercise
end_ stage_heart_ failure ABCd_ classification American_ College_of_ Cardiology accAmerican_ Heart_association AHA New_York_heart_association nyha structural_ heart_ disease heart failure
mva continuity_equationLV end-diastolic_ volume LV_ end-systolic_ volume mitral_ filling_ flow mVA velocity_ time integral mitral_ filling_ flow continuous_ wave doppler_echocardiography MR mitral_ valve_plasty
statitistical_ significance RM mortality sts HH cri TM
HFPSI Ann arbor Veterans_ Affairs HF_ clinic va-rt_cohort HFPSI va-RT_cohort HFPSI HFPSI
AAs spironolactone dose hyperkalemiapotassiumpotassium hypokalemiapotassium
preserved_ LVEF long-term_ mortality LVEFhazard_ ratioHR preserved_ LVEF
HFpEF male_ genderodds_ ratio nyha_ class_ III walk_ test mt
echo-derived pulmonary_ arterial_systolic_ pressurePASp right_ ventricular v tricuspid_ annular_ plane_ systolic_excursionTAPSe diastole end-systole heart failureHF cardiac_risk
severe_ CAD diabetes electrocardiographic_q_ waves left_ bundle_ branch_ block nondiabetes dyslipidemia hypertension tobacco_ useodds_ ratio
receiver_ operating_ characteristic_curve e/e_ ratios pcwp confidence_ interval ege_septal e/elateral
trastuzumab-treated patients coronary_ artery diseaseHR hypertensionHR weekly_ trastuzumab_administration h CHF
LVEF clinical_composite_ response cRT_on cRT_ OFF LV_ end_ systolic_ volume index LV_ mass
tGF-β_signaling tGF-β_ receptor_type_ I smad small-molecule_ inhibitors c-Kit_+_ cell yield epithelial mesenchymal_ transition markers pluripotency_ marker nanog c-Kit_+_ cell differentiation cardiomyocyte-like_ cells
hFref diuretics co-morbidities wha_class_ III
HF postoperative_echocardiography LV end-diastolic_ volume index LV ejection fraction MR preserved mitral_ valve opening mitral_ valve mVA pressure gradient
systolic_heart_ failure ivabradine SHIft systolic_ Heart_ Failure If_inhibitor_ ivabradine_trial ivabradine
Hazard_ ratios tAPse pasphazard_ ratio tAPse ncw_heart_association functional_ class
Renal_function Chronic_ Kidney Disease Epidemiology_collaboration equation glomerular_filteration_ rate egFR mL/min
paradigm-HF chronic_heart failure systolic_ dysfunctionLV_ef functional_ class NYHA_ II-III bNP bNPcardiovascular_ death hospitalization heart failure arni lz696 sacubiltril valsartan
hyperkalemia African_Americans non-AAs white New York_ Heart_associationNYha class III HF left_ ventricular_ dysfunction spironolactone aldactone_evaluation_ StudyRALes
LV_ reverse_ remodeling left_ ventricle left_atrial_ area right_ ventricular_en-diastolic_index right_atrial_ area right_ ventricular_fractional_ area
b-type_natriuretic_peptide n-terminal_pro-b-type_natriuretic_peptide coronary_ artery disease natriuretic_peptide bNP n-terminal_ fragment nt-probNP ventricular_ cardiomyocytes ventricular_wind stress myocardial_ischemia
iRS1 iRS2 heart hyperinsulinemia myocardial_ insulin resistance cellular_ dysfunction iRS2 heart-specific iRS1 iRS2 iRS2 double-knockout h-dko liver-specific iRS1 iRS2 iRS2 double-knockout l-dko
angiotensin-converting_ enzyme inhibitorsangiotensin_ receptor_blockers interquartile_ range β-blockers interquartile_ range
ivabradine diastolic_metral_ flow_ velocity early_ diastolic_metral_ annular_ velocity exercise_ capacity ivabradine
Low-strength liberal_transfusion_ protocols aggressive_ protocols significant_risk commissie acute_ coronary_ syndrome
unplanned_ readmission familiar_ physician adjusted_ hazard_ ratioHR confidence_ interval CI unfamiliar_ physician adjusted_HR ci ci
hek human_embryonic_ kidney cells overexpressing β1AR s1PR1 β1AR_ downregulation sphingosine-1-phosphate s1PR1_ agonist isoproterenol β-adrenergic_ receptor_ agonist
kansas_city_cardiomyopathy_ Questionnaire Minnesota Living_ with_heart_ Failure_ Questionnaire depressive symptoms beck_depression_inventory zung natriuretic_peptide endothelial_ functionflow-mediated_dilatation left_ ventricular_diastolic_function
odds_ ratios cardiovascular_ events atrial_fibrillation left_ ventricular_ejection_fraction diabetes mellitus peripheral_vascular_ disease myocardial_infarction heart failure stroke glomerular_ filtration_ rate acute_ kidney injury
diastolic_function Ea ventricular-arterial_ coupling ees ea
hazard_ ratios disease_risk_ score dRS_-stratified_analyses saxagliptin sitagliptin ci saxagliptin pioglitazone saxagliptin sulfonylureas ci saxagliptin insulin
i revascularization coronary_ artery_ bypass surgery hazard ratio percutaneous_ coronary_intervention HR systolic_ blood pressure left bundle_ branch_ block_ pattern baseline_ electrocardiogram IE
biomedical_ treatment biomedical_ treatment CHm left_ ventricular_ejection_fraction left_ ventricular_diastolic_ end_ diameter
open-label_ crossover_studies cardiovascular_ failure ventricular_ejection fraction arg16 gln27 gly16 glu27 haplotype β2-receptor carvedilol metoprolol
low-volume_ed_ cases aOR high-volume_ed_comité aOR
health_ Buddy_programhazard_ ratioHR confidence_ intervalCI quarterly inpatient_admissions
multivariable-adjusted_ hazard_ ratios
ctnt NT-probNPlaboratory_report aRIC_HF systolic_ blood pressure antihypertensive medication smoking diabetes body mass index coronary_heart disease heart rate HF receiver_ operating_ characteristic_curve eg discrimination net_ reclassification_ improvement nRI
eplerenone hyperkalemia renal_function wRF EMPHASIS-HF heart failure reduced_ejection_fraction h-ref New York_ Heart_association nyha glomerular_ filtration rate e gFR serum_potassium
low-dose_ nesiritide cumulative_ urine volumenesiritide placebo cystatin_c_ levelnesiritide
Nordic_ walking functional_ capacity mMWt physical_activiteit right_ grip_ strength kwh
hyperkalemia wr diabetes egFR systolic_ blood_ pressure ptassium hyperkalemia study-drug_ discontinuation wr cardiovascular_ mortality
PAf biosynthetic_ enzymeslyso-paf_acetyltransferaselyso-paf-at dithiothreitol cdp choline 1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase pbf-cpt catabolic_ isoenzymes pbf-acetylhydrolase pbf-AH lipoprotein-associated_phospholipase lp-PLA2]
ivabradine_groep follow-up_ exercise_ capacity peak_ oxygen_uptake
CHF ods_ratio hct chest_ radiation hypertension NAD(ph-oxidase_ subunit RAC2 hfe doxorubicin_efflux_ transporter ABCc2
NYha classification class_ II class_ III class_ I patient Duke_activity_status_index Duke_activity_status_index Kansas City_cariomyopathy_ Questionnaire
low-dose_ dopamine cumulative_ urine volumedopamine
haard_ ratio cc baseline_ glomerular_filteration_ rate h ml/min_ decrease chronic_obstructive_ pulmonary disease diabetes (HR peripheral_vascular_ diseaseHR left_ ventricular_ejection_fraction fraction iCD_ shocks New_York_heart_association_ class atrial_fibrillation congestive_HF
peak_ oxygen_uptake hazard_ ratio confidence_ interval cis ventilatory_ efficiency_ slope hemoglobin left_ ventricular_ejection_fraction HR=00.948 renal_function renal_ disease sodium
Kansas City_cardiomyopathy_ Questionnaire Minnesota Living_ with_ Heart_ Failure_ Questionnaire Beck_depression_inventory zung flow-mediated_dilatation diameter fes_groep natriuretic_peptide mitral_e/e_wave_ ratio
